{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:21:40Z","timestamp":1793848900480,"version":"4.6.1"},"reference-count":494,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"\n The persistence of increased excitability and spontaneous activity in injured peripheral neurons is imperative for the development and persistence of many forms of neuropathic pain. This aberrant activity involves increased activity and\/or expression of voltage-gated Na\n +<\/jats:sup>\n and Ca\n 2+<\/jats:sup>\n channels and hyperpolarization activated cyclic nucleotide gated (HCN) channels as well as decreased function of K\n +<\/jats:sup>\n channels. Because they display limited central side effects, peripherally restricted Na\n +<\/jats:sup>\n and Ca\n 2+<\/jats:sup>\n channel blockers and K\n +<\/jats:sup>\n channel activators offer potential therapeutic approaches to pain management. This review outlines the current status and future therapeutic promise of peripherally acting channel modulators. Selective blockers of Na\n v<\/jats:sub>\n 1.3, Na\n v<\/jats:sub>\n 1.7, Na\n v<\/jats:sub>\n 1.8, Ca\n v<\/jats:sub>\n 3.2, and HCN2 and activators of K\n v<\/jats:sub>\n 7.2 abrogate signs of neuropathic pain in animal models. Unfortunately, their performance in the clinic has been disappointing; some substances fail to meet therapeutic end points whereas others produce dose-limiting side effects. Despite this, peripheral voltage-gated cation channels retain their promise as therapeutic targets. The way forward may include (i) further structural refinement of K\n +<\/jats:sup>\n channel activators such as retigabine and ASP0819 to improve selectivity and limit toxicity; use or modification of Na\n +<\/jats:sup>\n channel blockers such as vixotrigine, PF-05089771, A803467, PF-01247324, VX-150 or arachnid toxins such as Tap1a; the use of Ca\n 2+<\/jats:sup>\n channel blockers such as TTA-P2, TTA-A2, Z 944, ACT709478, and CNCB-2; (ii) improving methods for assessing \u201cpain\u201d as opposed to nociception in rodent models; (iii) recognizing sex differences in pain etiology; (iv) tailoring of therapeutic approaches to meet the symptoms and etiology of pain in individual patients\n via<\/jats:italic>\n quantitative sensory testing and other personalized medicine approaches; (v) targeting genetic and biochemical mechanisms controlling channel expression using anti-NGF antibodies such as tanezumab or re-purposed drugs such as vorinostat, a histone methyltransferase inhibitor used in the management of T-cell lymphoma, or cercosporamide a MNK 1\/2 inhibitor used in treatment of rheumatoid arthritis; (vi) combination therapy using drugs that are selective for different channel types or regulatory processes; (vii) directing preclinical validation work toward the use of human or human-derived tissue samples; and (viii) application of molecular biological approaches such as clustered regularly interspaced short palindromic repeats (CRISPR) technology.\n <\/jats:p>","DOI":"10.3389\/fpain.2021.750583","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:19:30Z","timestamp":1639354770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":79,"title":["Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets"],"prefix":"10.3389","volume":"2","author":[{"given":"Sascha R. A.","family":"Alles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/pr.117.014399","article-title":"The etiology and pharmacology of neuropathic pain","volume":"70","author":"Alles","year":"2018","journal-title":"Pharmacol Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1097\/j.pain.0000000000001040","article-title":"Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain","volume":"158","author":"Bannister","year":"2017","journal-title":"Pain."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1113\/JP274165","article-title":"The plasticity of descending controls in pain: translational probing","volume":"595","author":"Bannister","year":"2017","journal-title":"J Physiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.pain.2014.04.018","article-title":"Peripheral nervous system origin of phantom limb pain","volume":"155","author":"Vaso","year":"2014","journal-title":"Pain."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1097\/j.pain.0000000000001602","article-title":"Suppression of neuropathic pain by selective silencing of dorsal root ganglion ectopia using nonblocking concentrations of lidocaine","volume":"160","author":"Yatziv","year":"2019","journal-title":"Pain."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1097\/j.pain.0000000000001527","article-title":"Peripheral afferents and the pain experience","volume":"160","author":"Waxman","year":"2019","journal-title":"Pain."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nm.2235","article-title":"Nociceptor sensitization in pain pathogenesis","volume":"16","author":"Gold","year":"2010","journal-title":"Nat Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu Rev Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/0006-8993(78)90548-6","article-title":"Ongoing activity in severed nerves: source and variation with time","volume":"159","author":"Govrin-Lippmann","year":"1978","journal-title":"Brain Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/brain\/awz063","article-title":"Electrophysiological and transcriptomic correlates of neuropathic pain in human dorsal root ganglion neurons","volume":"142","author":"North","year":"2019","journal-title":"Brain."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1097\/j.pain.0000000000001536","article-title":"The role of afferent input in postamputation pain: a randomized, double-blind, placebo-controlled crossover study","volume":"160","author":"Buch","year":"2019","journal-title":"Pain."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.pain.2014.03.022","article-title":"Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy","volume":"155","author":"Haroutounian","year":"2014","journal-title":"Pain."},{"key":"B15","doi-asserted-by":"publisher","first-page":"615362","DOI":"10.3389\/fnins.2020.615362","article-title":"Comparative analysis of dorsal root, nodose and sympathetic ganglia for the development of new analgesics","volume":"14","author":"Sapio","year":"2020","journal-title":"Front Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.amjopharm.2004.09.004","article-title":"Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia","volume":"2","author":"Parsons","year":"2004","journal-title":"Am J Geriatr Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fpain.2021.698157","article-title":"Mediators of neuropathic pain; focus on spinal microglia, CSF-1, BDNF, CCL21, TNF-alpha, Wnt ligands, and Interleukin 1-beta","volume":"2","author":"Boakye","year":"2021","journal-title":"Front Pain Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","article-title":"Immune and inflammatory mechanisms in neuropathic pain","volume":"51","author":"Moalem","year":"2006","journal-title":"Brain Res Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1152\/jn.00587.2011","article-title":"Long-term IL-1beta exposure causes subpopulation-dependent alterations in rat dorsal root ganglion neuron excitability","volume":"107","author":"Stemkowski","year":"2012","journal-title":"J Neurophysiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1113\/JP270905","article-title":"Increased excitability of medium-sized dorsal root ganglion neurons by prolonged interleukin-1beta exposure is K(+) channel dependent and reversible","volume":"593","author":"Stemkowski","year":"2015","journal-title":"J Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jneuroim.2019.05.002","article-title":"Long-term actions of interleukin-1\u03b2 on K+, Na+ Ca2+ channel currents in small, IBsb4\/s-positive dorsal root ganglion neurons possible relevance to the etiology of neuropathic pain","volume":"332","author":"Noh","year":"2019","journal-title":"J Neuroimmunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nn.3602","article-title":"Regulating excitability of peripheral afferents: emerging ion channel targets","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coph.2016.10.002","article-title":"Transient Receptor Potential Channels in neuropathic pain","volume":"32","author":"Basso","year":"2017","journal-title":"Curr Opin Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"eaam6072","DOI":"10.1126\/scitranslmed.aam6072","article-title":"Hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy","volume":"9","author":"Tsantoulas","year":"2017","journal-title":"Sci Transl Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1042\/BCJ20160287","article-title":"HCN2 ion channels: basic science opens up possibilities for therapeutic intervention in neuropathic pain","volume":"473","author":"Tsantoulas","year":"2016","journal-title":"Biochem J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fncel.2020.566418","article-title":"K+ channels in primary afferents and their role in pain produced by peripheral nerev injury","volume":"14","author":"Smith","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3959(95)00216-2","article-title":"Spontaneous action potential activity in isolated dorsal root ganglion neurons from rats with a painful neuropathy","volume":"65","author":"Study","year":"1996","journal-title":"Pain."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1097\/j.pain.0000000000001224","article-title":"Hyperpolarization-activated cyclic nucleotide-gated channels contribute to spontaneous activity in L4 C-fiber nociceptors, but not Abeta-non-nociceptors, after axotomy of L5-spinal nerve in the rat in vivo","volume":"159","author":"Djouhri","year":"2018","journal-title":"Pain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1152\/jn.2001.85.2.630","article-title":"Axotomy and autotomy-induced changes in the excitability of rat dorsal root ganglion neurons","volume":"85","author":"Abdulla","year":"2001","journal-title":"J Neurophysiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0306-4522(01)00161-0","article-title":"Hyperexcitability in sensory neurons of rats selected for high versus low neuropathic pain phenotype","volume":"105","author":"Liu","year":"2001","journal-title":"Neuroscience."},{"key":"B33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0304-3959(79)90002-2","article-title":"Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa","volume":"7","author":"Wall","year":"1979","journal-title":"Pain."},{"key":"B34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.expneurol.2008.08.003","article-title":"Governing role of primary afferent drive in increased excitation of spinal nociceptive neurons in a model of sciatic neuropathy","volume":"214","author":"Pitcher","year":"2008","journal-title":"Exp Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00221-009-1724-6","article-title":"Ectopic discharge in Abeta afferents as a source of neuropathic pain","volume":"196","author":"Devor","year":"2009","journal-title":"Exp Brain Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pain.2009.04.013","article-title":"Differential regulation of TRP channels in a rat model of neuropathic pain","volume":"144","author":"Staaf","year":"2009","journal-title":"Pain."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12990-015-0004-7","article-title":"Peripherally increased artemin is a key regulator of TRPA1\/V1 expression in primary afferent neurons","volume":"11","author":"Ikeda-Miyagawa","year":"2015","journal-title":"Mol Pain."},{"key":"B38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12974-021-02151-w","article-title":"TNF-alpha acutely enhances acid-sensing ion channel currents in rat dorsal root ganglion neurons via a p38 MAPK pathway","volume":"18","author":"Wei","year":"2021","journal-title":"J Neuroinflamm."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40265-020-01429-2","article-title":"TRPV1-targeted drugs in development for human pain conditions","volume":"81","author":"Iftinca","year":"2020","journal-title":"Drugs."},{"key":"B40","doi-asserted-by":"publisher","first-page":"114309","DOI":"10.1016\/j.bcp.2020.114309","article-title":"Nociceptive signaling mediated by P2X3, P2X4 and P2X7 receptors","volume":"187","author":"Inoue","year":"2021","journal-title":"Biochem Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/01616412.2020.1723313","article-title":"miR-384-5p ameliorates neuropathic pain by targeting SCN3A in a rat model of chronic constriction injury","volume":"42","author":"Ye","year":"2020","journal-title":"Neurol Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fnmol.2017.00126","article-title":"MiR-30b attenuates neuropathic pain by regulating voltage-gated sodium channel Nav1.3 in rats","volume":"10","author":"Su","year":"2017","journal-title":"Front Mol Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11064-013-1192-z","article-title":"Intrathecal miR-96 inhibits Nav1.3 expression and alleviates neuropathic pain in rat following chronic construction injury","volume":"39","author":"Chen","year":"2014","journal-title":"Neurochem Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1039\/C7MD00131B","article-title":"The discovery of a potent Nav1.3 inhibitor with good oral pharmacokinetics","volume":"8","author":"Pryde","year":"2017","journal-title":"Medchemcomm."},{"key":"B45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/brain\/awy329","article-title":"Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial","volume":"142","author":"de Greef","year":"2019","journal-title":"Brain."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/j.pain.0000000000001227","article-title":"Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy","volume":"159","author":"McDonnell","year":"2018","journal-title":"Pain."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/JPR.S247182","article-title":"Design of phase 3 studies evaluating vixotrigine for treatment of trigeminal neuralgia","volume":"13","author":"Kotecha","year":"2020","journal-title":"J Pain Res."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15327","article-title":"Fifteen years of NaV 1.7 channels as an analgesic target: why has excellent in vitro pharmacology not translated into in vivo analgesic efficacy?","author":"Eagles","year":"2020","journal-title":"Br J Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/j.pain.0000000000002041","article-title":"A spider-venom peptide with multitarget activity on sodium and calcium channels alleviates chronic visceral pain in a model of irritable bowel syndrome","volume":"162","author":"Cardoso","year":"2021","journal-title":"Pain."},{"key":"B50","doi-asserted-by":"publisher","first-page":"742457","DOI":"10.3389\/fmolb.2021.742457","article-title":"Engineering of a spider peptide via conserved structure-function traits optimizes sodium channel inhibition in vitro and anti-nociception in vivo","volume":"8","author":"Hu","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.neuron.2021.03.012","article-title":"A central mechanism of analgesia in mice and humans lacking the sodium channel NaV1.7","volume":"109","author":"MacDonald","year":"2021","journal-title":"Neuron."},{"key":"B52","doi-asserted-by":"publisher","first-page":"8967","DOI":"10.1038\/ncomms9967","article-title":"Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav17","volume":"6","author":"Minett","year":"2015","journal-title":"Nat Commun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1097\/j.pain.0000000000001567","article-title":"Antiallodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute postsurgical pain: evidence for analgesic synergy with opioids and baclofen","volume":"160","author":"Mueller","year":"2019","journal-title":"Pain."},{"key":"B54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.neuron.2019.01.047","article-title":"Defining the functional role of NaV1.7 in human nociception","volume":"101","author":"McDermott","year":"2019","journal-title":"Neuron."},{"key":"B55","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1126\/scitranslmed.aay9056","article-title":"Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice","volume":"13","author":"Moreno","year":"2021","journal-title":"Sci Transl Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1093\/pm\/pnab032","article-title":"A phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults","volume":"22","author":"Hijma","year":"2021","journal-title":"Pain Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/joacp.JOACP_155_18","article-title":"Tanezumab: therapy targeting nerve growth factor in pain pathogenesis","volume":"34","author":"Patel","year":"2018","journal-title":"J Anaesthesiol Clin Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"114291","DOI":"10.1016\/j.bcp.2020.114291","article-title":"Small cyclic sodium channel inhibitors","volume":"183","author":"Peigneur","year":"2021","journal-title":"Biochem Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/ALN.0b013e3181a915e7","article-title":"Coapplication of lidocaine and the permanently charged sodium channel blocker QX-314 produces a long-lasting nociceptive blockade in rodents","volume":"111","author":"Binshtok","year":"2009","journal-title":"Anesthesiology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"M3905","DOI":"10.1111\/bph.15531","article-title":"Inhibition of inflammatory pain and cough by a novel charged sodium channel blocker","volume":"178","author":"Tochitsky","year":"2021","journal-title":"Br J Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1152\/jn.00012.2013","article-title":"Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314","volume":"109","author":"Puopolo","year":"2013","journal-title":"J Neurophysiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1124\/jpet.119.264507","article-title":"Isoform-selective KCNA1 potassium channel openers built from glycine","volume":"373","author":"Manville","year":"2020","journal-title":"J Pharmacol Exp Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fnins.2019.00346","article-title":"Normalizing HDAC2 levels in the spinal cord alleviates thermal and mechanical hyperalgesia after peripheral nerve injury and promotes GAD65 and KCC2 expression","volume":"13","author":"Ouyang","year":"2019","journal-title":"Front Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neuroscience.2018.02.026","article-title":"Suppression of HDAC2 in spinal cord alleviates mechanical hyperalgesia and restores KCC2 expression in a rat model of bone cancer pain","volume":"377","author":"Hou","year":"2018","journal-title":"Neuroscience."},{"key":"B66","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12974-020-01740-5","article-title":"Suppression of histone deacetylases by SAHA relieves bone cancer pain in rats via inhibiting activation of glial cells in spinal dorsal horn and dorsal root ganglia","volume":"17","author":"He","year":"2020","journal-title":"J Neuroinflamm."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1097\/j.pain.0000000000001255","article-title":"Mice lacking Kcns1 in peripheral neurons show increased basal and neuropathic pain sensitivity","volume":"159","author":"Tsantoulas","year":"2018","journal-title":"Pain."},{"key":"B68","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nrd.2017.87","article-title":"Breaking barriers to novel analgesic drug development","volume":"16","author":"Yekkirala","year":"2017","journal-title":"Nat Rev Drug Discov."},{"key":"B69","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/164_2021_458","article-title":"Pharmacological activation of neuronal voltage-gated Kv7\/KCNQ\/M-channels for potential therapy of epilepsy and pain","volume":"267","author":"Liu","year":"2021","journal-title":"Handb Exp Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1124\/jpet.120.000357","article-title":"Activation of neuronal voltage-gated potassium Kv7\/KCNQ\/M-current by a novel channel opener SCR2682 for alleviation of chronic pain","volume":"377","author":"Wang","year":"2021","journal-title":"J Pharmacol Exp Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1038\/s41467-018-06339-2","article-title":"Ancient and modern anticonvulsants act synergistically in a KCNQ potassium channel binding pocket","volume":"9","author":"Manville","year":"2018","journal-title":"Nat Commun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"11349","DOI":"10.1096\/fj.201900485R","article-title":"Cilantro leaf harbors a potent potassium channel-activating anticonvulsant","volume":"33","author":"Manville","year":"2019","journal-title":"FASEB J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"32201","DOI":"10.1074\/jbc.M114.577528","article-title":"Modulation of the voltage-gated potassium channel (Kv4.3) and the auxiliary protein (KChIP3) interactions by the current activator NS5806","volume":"289","author":"Gonzalez","year":"2014","journal-title":"J Biol Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1111\/j.1476-5381.2010.00859.x","article-title":"Effect of the I(to) activator NS5806 on cloned K(V)4 channels depends on the accessory protein KChIP2","volume":"160","author":"Lundby","year":"2010","journal-title":"Br J Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1523\/JNEUROSCI.2036-20.2021","article-title":"Kv4.3 channel dysfunction contributes to trigeminal neuropathic pain manifested with orofacial cold hypersensitivity in rats","volume":"41","author":"Kanda","year":"2021","journal-title":"J Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1213\/ANE.0000000000001411","article-title":"The antiallodynic effects of nefopam are mediated by the adenosine triphosphate-sensitive potassium channel in a neuropathic pain model","volume":"123","author":"Koh","year":"2016","journal-title":"Anesth Analg."},{"key":"B77","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/FBP.0b013e32834eafbc","article-title":"The peripheral L-arginine-nitric oxide-cyclic GMP pathway and ATP-sensitive K(+) channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats","volume":"23","author":"Gutierrez","year":"2012","journal-title":"Behav Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.pain.2011.08.003","article-title":"Reopening of ATP-sensitive potassium channels reduces neuropathic pain and regulates astroglial gap junctions in the rat spinal cord","volume":"152","author":"Wu","year":"2011","journal-title":"Pain."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.3390\/ijms20092251","article-title":"Modulation of SUR1 KATP channel subunit activity in the peripheral nervous system reduces mechanical hyperalgesia after nerve injury in mice","volume":"20","author":"Luu","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1744806917729305","DOI":"10.1177\/1744806917729305","article-title":"Threshold effect of G9a\/Glp on peripheral nerve injury induced hypersensitivity","volume":"13","author":"Wang","year":"2017","journal-title":"Mol Pain."},{"key":"B81","doi-asserted-by":"publisher","first-page":"106","DOI":"10.31480\/2330-4871\/097","article-title":"BIX01294, a G9a inhibitor, alleviates nerve injury-induced pain hypersensitivities during both development and maintenance periods","volume":"6","author":"Liang","year":"2019","journal-title":"Transl Perioper Pain Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/nedt.2007.3.1.69","article-title":"Ziconotide: a review of its pharmacology and use in the treatment of pain","volume":"3","author":"McGivern","year":"2007","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2015.01.054","article-title":"ZC88, a novel N-type calcium channel blocker from 4-amino-piperidine derivatives state-dependent inhibits Cav2.2 calcium channels","volume":"1605","author":"Zhang","year":"2015","journal-title":"Brain Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejphar.2008.02.066","article-title":"Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence","volume":"586","author":"Meng","year":"2008","journal-title":"Eur J Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1152\/jn.00463.2013","article-title":"A mixed Ca2+ channel blocker, A-1264087, utilizes peripheral and spinal mechanisms to inhibit spinal nociceptive transmission in a rat model of neuropathic pain","volume":"111","author":"Xu","year":"2014","journal-title":"J Neurophysiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuroscience.2015.03.057","article-title":"Electrophysiological characterization of activation state-dependent Ca(v)2 channel antagonist TROX-1 in spinal nerve injured rats","volume":"297","author":"Patel","year":"2015","journal-title":"Neuroscience."},{"key":"B87","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1124\/jpet.110.166363","article-title":"Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker","volume":"334","author":"Abbadie","year":"2010","journal-title":"J Pharmacol Exp Ther."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/00000542-199206000-00044","article-title":"Postherpetic neuralgia: a possible application for topical clonidine","volume":"76","author":"Kirkpatrick","year":"1992","journal-title":"Anesthesiology."},{"key":"B89","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/pharmaceutics13040450","article-title":"Topical treatments and their molecular\/cellular mechanisms in patients with peripheral neuropathic pain-narrative review","volume":"13","author":"Kocot-Kepska","year":"2021","journal-title":"Pharmaceutics."},{"key":"B90","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neuroscience.2020.12.021","article-title":"Analgesic efficacy of alpha2 adrenergic receptor agonists depends on the chronic state of neuropathic pain: role of regulator of g protein signaling 4","volume":"455","author":"Yoon","year":"2021","journal-title":"Neuroscience."},{"key":"B91","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0304-3959(92)90092-P","article-title":"Transdermal clonidine versus placebo in painful diabetic neuropathy","volume":"48","author":"Zeigler","year":"1992","journal-title":"Pain."},{"key":"B92","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/rapm.2002.29244","article-title":"Intrathecal baclofen: a useful agent in the treatment of well-established complex regional pain syndrome","volume":"27","author":"Zuniga","year":"2002","journal-title":"Reg Anesth Pain Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol Rev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature11033","article-title":"alpha2delta expression sets presynaptic calcium channel abundance and release probability","volume":"486","author":"Hoppa","year":"2012","journal-title":"Nature."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1152\/jn.00168.2014","article-title":"Analysis of the long-term actions of gabapentin and pregabalin in dorsal root ganglia and substantia gelatinosa","volume":"112","author":"Biggs","year":"2014","journal-title":"J Neurophysiol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48118","article-title":"Novel charged sodium and calcium channel inhibitor active against neurogenic inflammation","author":"Lee","year":"2019","journal-title":"Elife."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/ejp.1221","article-title":"Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: a proof-of-concept, randomized, double-blind and controlled trial","volume":"22","author":"Kerckhove","year":"2018","journal-title":"Eur J Pain."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1177\/1744806916642444","article-title":"A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain","author":"Garcia-Caballero","year":"2016","journal-title":"Mol Pain."},{"key":"B100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12990-015-0011-8","article-title":"Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain","volume":"11","author":"Gadotti","year":"2015","journal-title":"Mol Pain."},{"key":"B101","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/13543776.2018.1541982","article-title":"T-type calcium channel blockers: a patent review (2012-2018)","volume":"28","author":"Nam","year":"2018","journal-title":"Expert Opin Ther Pat."},{"key":"B102","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1523\/JNEUROSCI.3216-20.2021","article-title":"Cannabidiol inhibition of murine primary nociceptors: tight binding to slow inactivated states of Nav1.8 channels","volume":"41","author":"Zhang","year":"2021","journal-title":"J Neurosci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2019.01.007","article-title":"Cannabinoids-induced peripheral analgesia depends on activation of BK channels","volume":"1711","author":"Li","year":"2019","journal-title":"Brain Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"16124","DOI":"10.1074\/jbc.M707104200","article-title":"Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol","volume":"283","author":"Ross","year":"2008","journal-title":"J Biol Chem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1021\/cn500206a","article-title":"Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects","volume":"6","author":"Bladen","year":"2015","journal-title":"ACS Chem Neurosci."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14973","article-title":"A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans","author":"Arout","year":"2021","journal-title":"Br J Clin Pharmacol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1155\/2014\/754693","article-title":"Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society","volume":"19","author":"Moulin","year":"2014","journal-title":"Pain Res Manag."},{"key":"B109","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ejp.1118","article-title":"Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - an overview of systematic reviews","volume":"22","author":"Hauser","year":"2017","journal-title":"Eur J Pain."},{"key":"B110","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.1523\/JNEUROSCI.0220-17.2017","article-title":"The MNK-eIF4E signaling axis contributes to injury-induced nociceptive plasticity and the development of chronic pain","volume":"37","author":"Moy","year":"2017","journal-title":"J Neurosci."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1152\/jn.00913.2001","article-title":"Changes in Na+ channel currents of rat dorsal root ganglion neurons following axotomy and axotomy-induced autotomy","volume":"88","author":"Abdulla","year":"2002","journal-title":"J Neurophysiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0304-3959(99)00169-4","article-title":"Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain","volume":"83","author":"Dib-Hajj","year":"1999","journal-title":"Pain."},{"key":"B113","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0306-4522(01)00258-5","article-title":"Sodium currents of large (Abeta-type) adult cutaneous afferent dorsal root ganglion neurons display rapid recovery from inactivation before and after axotomy","volume":"106","author":"Everill","year":"2001","journal-title":"Neuroscience."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The role of voltage-gated sodium channels in pain signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol Rev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0006-8993(00)02774-8","article-title":"Sodium channels and their genes: dynamic expression in the normal nervous system, dysregulation in disease states(1)","volume":"886","author":"Waxman","year":"2000","journal-title":"Brain Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0896-6273(00)00116-1","article-title":"Nomenclature of voltage-gated sodium channels","volume":"28","author":"Goldin","year":"2000","journal-title":"Neuron."},{"key":"B117","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/pr.57.4.4","article-title":"International union of pharmacology. XLVII Nomenclature and structure-function relationships of voltage-gated sodium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol Rev."},{"key":"B118","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1111\/bph.14750","article-title":"The concise giude to pharmacology 2019\/20: ion channels","volume":"176","author":"Alexander","year":"2019","journal-title":"Br J Pharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/bja\/aen107","article-title":"Neuropathic pain: emerging treatments","volume":"101","author":"Dray","year":"2008","journal-title":"Br J Anaesth."},{"key":"B120","first-page":"682","article-title":"Future potential and status of selective sodium channel blockers for the treatment of pain","volume":"12","author":"Priest","year":"2009","journal-title":"Curr Opin Drug Discov Devel."},{"key":"B121","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.neuroscience.2009.08.037","article-title":"Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia","volume":"164","author":"Siqueira","year":"2009","journal-title":"Neuroscience."},{"key":"B122","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ana.21527","article-title":"Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas","volume":"64","author":"Black","year":"2008","journal-title":"Ann Neurol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.celrep.2013.12.033","article-title":"Pain without nociceptors? Nav1.7-independent pain mechanisms","volume":"6","author":"Minett","year":"2014","journal-title":"Cell Rep."},{"key":"B124","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ncomms1795","article-title":"Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons","volume":"3","author":"Minett","year":"2012","journal-title":"Nat Commun."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e104458","DOI":"10.1371\/journal.pone.0104458","article-title":"Significant determinants of mouse pain behaviour","volume":"9","author":"Minett","year":"2014","journal-title":"PLoS ONE."},{"key":"B126","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1002\/j.1460-2075.1989.tb08534.x","article-title":"Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development","volume":"8","author":"Beckh","year":"1989","journal-title":"EMBO J."},{"key":"B127","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1152\/jn.1994.72.1.466","article-title":"Type III sodium channels mRNA is expressed in embroyonic but not in adult spinal sensory neurons and is re-expressed following axotomy","volume":"72","author":"Waxman","year":"1994","journal-title":"J Neurophysiol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.1523\/JNEUROSCI.21-16-05952.2001","article-title":"Nav1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons","volume":"21","author":"Cummins","year":"2001","journal-title":"J Neurosci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/mt.2012.169","article-title":"Virus-mediated shRNA knockdown of Na(v)1.3 in rat dorsal root ganglion attenuates nerve injury-induced neuropathic pain","volume":"21","author":"Samad","year":"2013","journal-title":"Mol Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1523\/JNEUROSCI.17-10-03503.1997","article-title":"Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury","volume":"17","author":"Cummins","year":"1997","journal-title":"J Neurosci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0079-6123(06)61013-3","article-title":"Sodium channel expression and the molecular pathophysiology of pain after SCI","volume":"161","author":"Hains","year":"2007","journal-title":"Prog Brain Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1523\/JNEUROSCI.0300-04.2004","article-title":"Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury","volume":"24","author":"Hains","year":"2004","journal-title":"J Neurosci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/brain\/awh623","article-title":"Changes in electrophysiological properties and sodium channel Nav1.3 expression in thalamic neurons after spinal cord injury","volume":"128","author":"Hains","year":"2005","journal-title":"Brain."},{"key":"B134","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0169-328X(02)00385-6","article-title":"Sodium channel Na(v)1.6 is expressed along nonmyelinated axons and it contributes to conduction","volume":"105","author":"Black","year":"2002","journal-title":"Brain Res Mol Brain Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1073\/pnas.090034797","article-title":"Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses","volume":"97","author":"Caldwell","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.pain.2013.02.027","article-title":"Knockdown of sodium channel NaV1.6 blocks mechanical pain and abnormal bursting activity of afferent neurons in inflamed sensory ganglia","volume":"154","author":"Xie","year":"2013","journal-title":"Pain."},{"key":"B137","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1038\/s41598-018-22216-w","article-title":"Conditional knockout of NaV16 in adult mice ameliorates neuropathic pain","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep."},{"key":"B138","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.neuroscience.2015.02.010","article-title":"Local knockdown of the NaV1.6 sodium channel reduces pain behaviors, sensory neuron excitability, and sympathetic sprouting in rat models of neuropathic pain","volume":"291","author":"Xie","year":"2015","journal-title":"Neuroscience."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1093\/brain\/awaa208","article-title":"Sodium channel Nav1.6 in sensory neurons contributes to vincristine-induced allodynia","volume":"143","author":"Chen","year":"2020","journal-title":"Brain."},{"key":"B140","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/ana.10364","article-title":"Changes of sodium channel expression in experimental painful diabetic neuropathy","volume":"52","author":"Craner","year":"2002","journal-title":"Ann Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2119\/molmed.2016.00131","article-title":"A gain-of-function mutation in Nav1.6 in a case of trigeminal neuralgia","volume":"22","author":"Tanaka","year":"2016","journal-title":"Mol Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1113\/JP278148","article-title":"NaV 1.6 regulates excitability of mechanosensitive sensory neurons","volume":"597","author":"Israel","year":"2019","journal-title":"J Physiol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/gt.2009.25","article-title":"Herpes virus-based recombinant herpes vectors: gene therapy for pain and molecular tool for pain science","volume":"16","author":"Yeomans","year":"2009","journal-title":"Gene Ther."},{"key":"B144","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1111\/bph.14461","article-title":"GpTx-1 and [Ala(5), Phe(6), Leu(26), Arg(28) ]GpTx-1, two peptide NaV 1.7 inhibitors: analgesic and tolerance properties at the spinal level","volume":"175","author":"Chen","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn3404","article-title":"The Na(V)1.7 sodium channel: from molecule to man","volume":"14","author":"Dib-Hajj","year":"2013","journal-title":"Nat Rev Neurosci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-070918-050144","article-title":"Sodium channels in human pain disorders: genetics and pharmacogenomics","volume":"42","author":"Dib-Hajj","year":"2019","journal-title":"Annu Rev Neurosci."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1073\/pnas.94.4.1527","article-title":"Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons","volume":"94","author":"Toledo-Aral","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B148","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1744-8069-8-82","article-title":"Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn","volume":"8","author":"Black","year":"2012","journal-title":"Mol Pain."},{"key":"B149","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1744-8069-9-39","article-title":"NaV1.7: stress-induced changes in immunoreactivity within magnocellular neurosecretory neurons of the supraoptic nucleus","volume":"9","author":"Black","year":"2013","journal-title":"Mol Pain."},{"key":"B150","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1113\/jphysiol.2011.215384","article-title":"Selective silencing of Na(V)1.7 decreases excitability and conduction in vagal sensory neurons","volume":"589","author":"Muroi","year":"2011","journal-title":"J Physiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1523\/JNEUROSCI.11-02-00435.1991","article-title":"Voltage-gated currents in identified rat olfactory receptor neurons","volume":"11","author":"Trombley","year":"1991","journal-title":"J Neurosci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1113\/jphysiol.2014.274209","article-title":"Na+ current properties in islet alpha- and beta-cells reflect cell-specific Scn3a and Scn9a expression","volume":"592","author":"Zhang","year":"2014","journal-title":"J Physiol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00701-002-0970-1","article-title":"Accumulation of PN1 and PN3 sodium channels in painful human neuroma-evidence from immunocytochemistry","volume":"144","author":"Kretschmer","year":"2002","journal-title":"Acta Neurochir."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1093\/brain\/awab113","article-title":"Paclitaxel increases axonal localization and vesicular trafficking of Nav1.7.","volume":"144","author":"Akin","year":"2021","journal-title":"Brain"},{"key":"B155","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/BF02450318","article-title":"Comparison of three rodent models of neuropathic pain","volume":"113","author":"Kim","year":"1997","journal-title":"Exp Brain Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/363543a0","article-title":"Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia","volume":"363","author":"McLachlan","year":"1993","journal-title":"Nature."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1523\/JNEUROSCI.17-05-01633.1997","article-title":"Ectopic \u03b1sb2\/s-adrenoceptors couple to N-type Ca2+ channels in axotomized rat sensory neurons","volume":"17","author":"Abdulla","year":"1997","journal-title":"J Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1097\/00001756-199809140-00035","article-title":"Sympathetic axons surround neuropeptide-negative axotomized sensory neurons","volume":"9","author":"Ramer","year":"1998","journal-title":"Neuroreport."},{"key":"B159","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/exnr.1998.6855","article-title":"Differences in sympathetic innervation of mouse DRG following proximal or distal nerve lesions","volume":"152","author":"Ramer","year":"1998","journal-title":"Exp Neurol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia","volume":"41","author":"Yang","year":"2004","journal-title":"J Med Genet."},{"key":"B161","doi-asserted-by":"publisher","first-page":"8232","DOI":"10.1523\/JNEUROSCI.2695-04.2004","article-title":"Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy","volume":"24","author":"Cummins","year":"2004","journal-title":"J Neurosci."},{"key":"B162","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/ALN.0000000000000476","article-title":"p.L1612P, a novel voltage-gated sodium channel Nav1.7 mutation inducing a cold sensitive paroxysmal extreme pain disorder","volume":"122","author":"Suter","year":"2015","journal-title":"Anesthesiology."},{"key":"B163","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.neuron.2006.10.006","article-title":"SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes","volume":"52","author":"Fertleman","year":"2006","journal-title":"Neuron."},{"key":"B164","doi-asserted-by":"publisher","first-page":"100227","DOI":"10.1074\/jbc.RA120.014288","article-title":"Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivity","volume":"296","author":"Kerth","year":"2021","journal-title":"J Biol Chem."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/j.pain.0000000000001511","article-title":"The role of Nasbv\/s1.7 in human nociceptors: insights from human induced pluripotent stem cell-derived sensory neurons of erythromelalgia patients","volume":"160","author":"Meents","year":"2019","journal-title":"Pain."},{"key":"B166","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/j.pain.0000000000001116","article-title":"Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy","volume":"159","author":"Blesneac","year":"2018","journal-title":"Pain."},{"key":"B167","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1744-8069-7-92","article-title":"Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7","volume":"7","author":"Estacion","year":"2011","journal-title":"Mol Pain."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1097\/j.pain.0000000000002171","article-title":"Two independent mouse lines carrying the Nav1.7 I228M gain-of-function variant display dorsal root ganglion neuron hyperexcitability but a minimal pain phenotype","volume":"162","author":"Chen","year":"2021","journal-title":"Pain."},{"key":"B169","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature."},{"key":"B170","doi-asserted-by":"publisher","first-page":"e105895","DOI":"10.1371\/journal.pone.0105895","article-title":"Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain","volume":"9","author":"Gingras","year":"2014","journal-title":"PLoS ONE."},{"key":"B171","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pharmtox-010617-052554","article-title":"The genetics of pain: implications for therapeutics","volume":"58","author":"Sexton","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"40883","DOI":"10.1038\/srep40883","article-title":"Pharmacological characterisation of the highly Nasbv\/s17 selective spider venom peptide Pn3a","volume":"7","author":"Deuis","year":"2017","journal-title":"Sci Rep."},{"key":"B173","doi-asserted-by":"publisher","first-page":"eaax4568","DOI":"10.1126\/sciadv.aax4568","article-title":"Sensory neuron-derived Na(V)17 contributes to dorsal horn neuron excitability","volume":"6","author":"Alles","year":"2020","journal-title":"Sci Adv."},{"key":"B174","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1517\/14728222.2016.1162295","article-title":"Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief","volume":"20","author":"Emery","year":"2016","journal-title":"Expert Opin Ther Targets."},{"key":"B175","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.eplepsyres.2014.11.021","article-title":"Current understanding of the mechanism of action of the antiepileptic drug lacosamide","volume":"110","author":"Rogawski","year":"2015","journal-title":"Epilepsy Res."},{"key":"B176","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1124\/mol.116.106401","article-title":"Lacosamide inhibition of Nav1.7 voltage-gated sodium channels: slow binding to fast-inactivated states","volume":"91","author":"Jo","year":"2017","journal-title":"Mol Pharmacol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/ncomms2184","article-title":"Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Na(V)17 mutant channel","volume":"3","author":"Yang","year":"2012","journal-title":"Nat Commun."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.bmcl.2017.03.085","article-title":"Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nasbv\/s1.7 inhibitors with pain efficacy in mice","volume":"27","author":"Roecker","year":"2017","journal-title":"Bioorg Med Chem Lett."},{"key":"B179","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1016\/j.bmcl.2017.04.040","article-title":"Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model","volume":"27","author":"Pero","year":"2017","journal-title":"Bioorg Med Chem Lett."},{"key":"B180","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.bmcl.2017.05.070","article-title":"The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: tools that bridge efficacy and target engagement","volume":"27","author":"La","year":"2017","journal-title":"Bioorg Med Chem Lett."},{"key":"B181","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1016\/j.celrep.2018.08.063","article-title":"Selective NaV1.7 antagonists with long residence time show improved efficacy against inflammatory and neuropathic pain","volume":"24","author":"Bankar","year":"2018","journal-title":"Cell Rep."},{"key":"B182","doi-asserted-by":"publisher","first-page":"10180","DOI":"10.1523\/JNEUROSCI.1049-18.2018","article-title":"Insensitivity to pain upon adult-onset deletion of Nav1.7 or its blockade with selective inhibitors","volume":"38","author":"Shields","year":"2018","journal-title":"J Neurosci."},{"key":"B183","doi-asserted-by":"publisher","first-page":"104346","DOI":"10.1016\/j.compbiomed.2021.104346","article-title":"In silico development of potential therapeutic for the pain treatment by inhibiting voltage-gated sodium channel 1.7","volume":"132","author":"Golubovic","year":"2021","journal-title":"Comput Biol Med."},{"key":"B184","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/molpharm.120.000079","article-title":"Characterization of vixotrigine, a broad-spectrum voltage-gated sodium channel blocker","volume":"99","author":"Hinckley","year":"2021","journal-title":"Mol Pharmacol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(17)30005-4","article-title":"Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial","volume":"16","author":"Zakrzewska","year":"2017","journal-title":"Lancet Neurol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1111\/bph.13081","article-title":"Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach","volume":"172","author":"Klint","year":"2015","journal-title":"Br J Pharmacol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.chembiol.2007.02.009","article-title":"Conotoxins containing nonnatural backbone spacers: cladistic-based design, chemical synthesis, and improved analgesic activity","volume":"14","author":"Green","year":"2007","journal-title":"Chem Biol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.1074\/jbc.M116.725978","article-title":"Engineering highly potent and selective microproteins against Nav1.7 sodium channel for treatment of pain","volume":"291","author":"Shcherbatko","year":"2016","journal-title":"J Biol Chem."},{"key":"B189","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fphar.2019.00366","article-title":"Structure-function and therapeutic potential of spider venom-derived cysteine knot peptides targeting sodium channels","volume":"10","author":"Cardoso","year":"2019","journal-title":"Front Pharmacol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"114107","DOI":"10.1016\/j.bcp.2020.114107","article-title":"Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases","volume":"181","author":"Cardoso","year":"2020","journal-title":"Biochem Pharmacol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/19336950.2015.1120392","article-title":"Modulation of human Nav1.7 channel gating by synthetic alpha-scorpion toxin OD1 and its analogs","volume":"10","author":"Motin","year":"2016","journal-title":"Channels."},{"key":"B192","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1021\/jm501765v","article-title":"Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel","volume":"58","author":"Murray","year":"2015","journal-title":"J Med Chem."},{"key":"B193","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1021\/acschembio.9b00183","article-title":"Engineering NaV1.7 inhibitory JzTx-V peptides with a potency and basicity profile suitable for antibody conjugation to enhance pharmacokinetics","volume":"14","author":"Murray","year":"2019","journal-title":"ACS Chem Biol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1124\/mol.115.098178","article-title":"Identification and characterization of ProTx-III [\u03bc-TRTX-Tp1a], a new voltage-gated sodium channel inhibitor from venom of the tarantula thrixopelma pruriens","volume":"88","author":"Cardoso","year":"2015","journal-title":"Mol Pharmacol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1111\/bph.13865","article-title":"Modulatory features of the novel spider toxin \u03bc-TRTX-Df1a isolated from the venom of the spider Davus fasciatus","volume":"174","author":"Cardoso","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"39662","DOI":"10.1038\/srep39662","article-title":"Insensitivity to pain induced by a potent selective closed-state Nav17 inhibitor","volume":"7","author":"Flinspach","year":"2017","journal-title":"Sci Rep."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0021-9258(17)49888-7","article-title":"Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNav1.7","volume":"295","author":"Neff","year":"2020","journal-title":"J Biol Chem."},{"key":"B198","doi-asserted-by":"publisher","first-page":"100326","DOI":"10.1016\/j.jbc.2021.100326","article-title":"Engineering of highly potent and selective HNTX-III mutant against hNav1.7 sodium channel for treatment of pain","volume":"296","author":"Zhang","year":"2021","journal-title":"J Biol Chem."},{"key":"B199","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/toxins10090358","article-title":"Engineering gain-of-function analogues of the spider venom peptide HNTX-I, a potent blocker of the hNaV1.7 sodium channel","volume":"10","author":"Zhang","year":"2018","journal-title":"Toxins."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1744806918778491","DOI":"10.1177\/1744806918778491","article-title":"Bulleyaconitine A attenuates hyperexcitability of dorsal root ganglion neurons induced by spared nerve injury: the role of preferably blocking Nav1.7 and Nav1.3 channels","volume":"14","author":"Xie","year":"2018","journal-title":"Mol Pain."},{"key":"B201","doi-asserted-by":"publisher","first-page":"112963","DOI":"10.1016\/j.jep.2020.112963","article-title":"Neoline, an active ingredient of the processed aconite root in Goshajinkigan formulation, targets Nav1.7 to ameliorate mechanical hyperalgesia in diabetic mice","volume":"259","author":"Nakatani","year":"2020","journal-title":"J Ethnopharmacol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.cell.2014.03.064","article-title":"A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief","volume":"157","author":"Lee","year":"2014","journal-title":"Cell."},{"key":"B203","doi-asserted-by":"publisher","first-page":"16750","DOI":"10.1038\/s41598-018-34755-3","article-title":"MicroRNA-182 alleviates neuropathic pain by regulating Nav17 following spared nerve injury in rats","volume":"8","author":"Cai","year":"2018","journal-title":"Sci Rep."},{"key":"B204","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuropharm.2017.09.018","article-title":"Voltage-gated sodium channel beta subunits: the power outside the pore in brain development and disease","volume":"132","author":"Hull","year":"2018","journal-title":"Neuropharmacology"},{"key":"B205","doi-asserted-by":"publisher","first-page":"15044","DOI":"10.1074\/jbc.M111.333740","article-title":"Differential expression of sodium channel beta subunits in dorsal root ganglion sensory neurons","volume":"287","author":"Ho","year":"2012","journal-title":"J Biol Chem."},{"key":"B206","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1152\/jn.00107.2011","article-title":"Regulation of Nav1.6 and Nav1.8 peripheral nerve Na+ channels by auxiliary beta-subunits","volume":"106","author":"Zhao","year":"2011","journal-title":"J Neurophysiol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0006-8993(92)91687-A","article-title":"Three types of sodium channels in adult rat dorsal root ganglion neurons","volume":"592","author":"Caffrey","year":"1992","journal-title":"Brain Res."},{"key":"B208","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1152\/jn.2000.84.2.710","article-title":"alpha -SNS produces the slow TTX-resistant sodium current in large cutaneous afferent DRG neurons","volume":"84","author":"Renganathan","year":"2000","journal-title":"J Neurophysiol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1113\/jphysiol.2003.042127","article-title":"The TTX-resistant sodium channel Nav1.8 (SNS\/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons","volume":"550","author":"Djouhri","year":"2003","journal-title":"J Physiol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1152\/jn.01033.2006","article-title":"Differential slow inactivation and use-dependent inhibition of Nav1.8 channels contribute to distinct firing properties in IB4+ and IB4\u0393\u00ea\u00c6 DRG neurons","volume":"97","author":"Choi","year":"2007","journal-title":"J Neurophysiol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.pain.2012.04.022","article-title":"Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system","volume":"153","author":"Shields","year":"2012","journal-title":"Pain."},{"key":"B212","doi-asserted-by":"publisher","first-page":"7190","DOI":"10.1523\/JNEUROSCI.5011-13.2014","article-title":"Tetrodotoxin-resistant sodium channels in sensory neurons generate slow resurgent currents that are enhanced by inflammatory mediators","volume":"34","author":"Tan","year":"2014","journal-title":"J Neurosci."},{"key":"B213","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1523\/JNEUROSCI.5541-09.2010","article-title":"Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain","volume":"30","author":"Uchida","year":"2010","journal-title":"J Neurosci."},{"key":"B214","doi-asserted-by":"publisher","first-page":"14950","DOI":"10.1073\/pnas.93.25.14950","article-title":"Down-regulation of transcripts for Na channel alpha-SNS in spinal sensory neurons following axotomy","volume":"93","author":"Dib-Hajj","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B215","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1152\/jn.1998.79.5.2668","article-title":"Rescue of alpha-SNS sodium channel expression in small dorsal root ganglion neurons after axotomy by nerve growth factor in vivo","volume":"79","author":"Dib-Hajj","year":"1998","journal-title":"J Neurophysiol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1523\/JNEUROSCI.23-01-00158.2003","article-title":"Redistribution of NaV1.8 in uninjured axons enables neuropathic pain","volume":"23","author":"Gold","year":"2003","journal-title":"J Neurosci."},{"key":"B217","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0304-3959(99)00251-1","article-title":"Immunolocalization of SNS\/PN3 and NaN\/SNS2 sodium channels in human pain states","volume":"85","author":"Coward","year":"2000","journal-title":"Pain."},{"key":"B218","doi-asserted-by":"publisher","first-page":"19444","DOI":"10.1073\/pnas.1216080109","article-title":"Gain-of-function Nav1.8 mutations in painful neuropathy","volume":"109","author":"Faber","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/ENEURO.0140-15.2016","article-title":"Optogenetic silencing of Nav1.8-positive afferents alleviates inflammatory and neuropathic pain","volume":"3","author":"Daou","year":"2016","journal-title":"eNeuro."},{"key":"B220","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00395-020-0780-8","article-title":"Inhibition of NaV1.8 prevents atrial arrhythmogenesis in human and mice","volume":"115","author":"Pabel","year":"2020","journal-title":"Basic Res Cardiol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"8520","DOI":"10.1073\/pnas.0611364104","article-title":"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat","volume":"104","author":"Jarvis","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B222","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1111\/bph.13092","article-title":"A novel selective and orally bioavailable Nasbv\/s1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability","volume":"172","author":"Payne","year":"2015","journal-title":"Br J Pharmacol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-020-00415-2","article-title":"Status of peripheral sodium channel blockers for non-addictive pain treatment","volume":"16","author":"Alsaloum","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"11829","DOI":"10.1074\/jbc.M116.721662","article-title":"Development of a muO-conotoxin analogue with improved lipid membrane interactions and potency for the analgesic sodium channel Nasbv\/s1.8","volume":"291","author":"Deuis","year":"2016","journal-title":"J Biol Chem"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1124\/jpet.107.134148","article-title":"A selective Nav1.8 sodium channel blocker, A-803467 [5-(4-chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], attenuates spinal neuronal activity in neuropathic rats","volume":"324","author":"McGaraughty","year":"2008","journal-title":"J Pharmacol Exp Ther."},{"key":"B226","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1523\/JNEUROSCI.20-23-08754.2000","article-title":"Glial-derived neurotrophic factor upregulates expression of functional SNS and NaN sodium channels and their currents in axotomized dorsal root ganglion neurons","volume":"20","author":"Cummins","year":"2000","journal-title":"J Neurosci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0014-5793(99)01519-7","article-title":"Two tetrodotoxin-resistant sodium channels in human dorsal root ganglion neurons","volume":"462","author":"Dib-Hajj","year":"1999","journal-title":"FEBS Lett."},{"key":"B228","doi-asserted-by":"publisher","first-page":"RC43","DOI":"10.1523\/JNEUROSCI.19-24-j0001.1999","article-title":"A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons","volume":"19","author":"Cummins","year":"1999","journal-title":"J Neurosci."},{"key":"B229","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0166-2236(02)02150-1","article-title":"NaN\/Nav1.9: a sodium channel with unique properties","volume":"25","author":"Dib-Hajj","year":"2002","journal-title":"Trends Neurosci."},{"key":"B230","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nrn3977","article-title":"NaV1.9: a sodium channel linked to human pain","volume":"16","author":"Dib-Hajj","year":"2015","journal-title":"Nat Rev Neurosci."},{"key":"B231","doi-asserted-by":"publisher","first-page":"8963","DOI":"10.1073\/pnas.95.15.8963","article-title":"NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy","volume":"95","author":"Dib-Hajj","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B232","doi-asserted-by":"publisher","first-page":"9382","DOI":"10.1073\/pnas.0501549102","article-title":"Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior","volume":"102","author":"Priest","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B233","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nature06191","article-title":"Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers","volume":"449","author":"Binshtok","year":"2007","journal-title":"Nature."},{"key":"B234","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1097\/ALN.0000000000001050","article-title":"Quaternary lidocaine derivative QX-314 activates and permeates human TRPV1 and TRPA1 to produce inhibition of sodium channels and cytotoxicity","volume":"124","author":"Stueber","year":"2016","journal-title":"Anesthesiology."},{"key":"B235","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1476-5381.2011.01391.x","article-title":"Targeting of sodium channel blockers into nociceptors to produce long-duration analgesia: a systematic study and review","volume":"164","author":"Roberson","year":"2011","journal-title":"Br J Pharmacol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1152\/jn.2001.85.2.644","article-title":"Axotomy- and autotomy-induced changes in Ca2+and K+ channel currents of rat dorsal root ganglion neurons","volume":"85","author":"Abdulla","year":"2001","journal-title":"J Neurophysiol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1152\/jn.1999.82.2.700","article-title":"Reduction of potassium currents in identified cutaneous afferent dorsal root ganglion neurons after axotomy","volume":"82","author":"Everill","year":"1999","journal-title":"J Neurophysiol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.neuroscience.2003.11.014","article-title":"Altered expression of potassium channel subunit mRNA and alpha-dendrotoxin sensitivity of potassium currents in rat dorsal root ganglion neurons after axotomy","volume":"123","author":"Yang","year":"2004","journal-title":"Neuroscience."},{"key":"B239","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.pain.2010.12.028","article-title":"Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury","volume":"152","author":"Rose","year":"2011","journal-title":"Pain"},{"key":"B240","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1471-4159.2012.07736.x","article-title":"Nerve injury increases brain-derived neurotrophic factor levels to suppress BK channel activity in primary sensory neurons","volume":"121","author":"Cao","year":"2012","journal-title":"J Neurochem."},{"key":"B241","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tins.2013.12.002","article-title":"Opening paths to novel analgesics: the role of potassium channels in chronic pain","volume":"37","author":"Tsantoulas","year":"2014","journal-title":"Trends Neurosci."},{"key":"B242","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1744-8069-7-5","article-title":"Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain","volume":"7","author":"Takeda","year":"2011","journal-title":"Mol Pain."},{"key":"B243","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejphar.2004.07.026","article-title":"Potassium channels and pain: present realities and future opportunities","volume":"500","author":"Ocana","year":"2004","journal-title":"Eur J Pharmacol."},{"key":"B244","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fnmol.2018.00253","article-title":"A-type KV channels in dorsal root ganglion neurons: diversity, function, and dysfunction","volume":"11","author":"Zemel","year":"2018","journal-title":"Front Mol Neurosci."},{"key":"B245","doi-asserted-by":"publisher","first-page":"e12661","DOI":"10.7554\/eLife.12661","article-title":"Altered potassium channel distribution and composition in myelinated axons suppresses hyperexcitability following injury","volume":"5","author":"Calvo","year":"2016","journal-title":"Elife."},{"key":"B246","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1124\/pr.57.4.9","article-title":"International Union of Pharmacology. LII Nomenclature and molecular relationships of calcium-activated potassium channels","volume":"57","author":"Wei","year":"2005","journal-title":"Pharmacol Rev."},{"key":"B247","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1124\/pr.57.4.10","article-title":"International Union of Pharmacology. LIII Nomenclature and molecular relationships of voltage-gated potassium channels","volume":"57","author":"Gutman","year":"2005","journal-title":"Pharmacol Rev."},{"key":"B248","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/pr.57.4.11","article-title":"International Union of Pharmacology. LIV Nomenclature and molecular relationships of inwardly rectifying potassium channels","volume":"57","author":"Kubo","year":"2005","journal-title":"Pharmacol Rev."},{"key":"B249","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1124\/pr.57.4.12","article-title":"International Union of Pharmacology. LV Nomenclature and molecular relationships of two-P potassium channels","volume":"57","author":"Goldstein","year":"2005","journal-title":"Pharmacol Rev."},{"key":"B250","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/nn.4165","article-title":"G9a is essential for epigenetic silencing of K+ channel genes in acute-to-chronic pain transition","volume":"18","author":"Laumet","year":"2015","journal-title":"Nat Neurosci."},{"key":"B251","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0306-4522(00)00263-3","article-title":"Nerve growth factor maintains potassium conductance after nerve injury in adult cutaneous afferent dorsal root ganglion neurons [In Process Citation]","volume":"100","author":"Everill","year":"2000","journal-title":"Neuroscience."},{"key":"B252","doi-asserted-by":"publisher","first-page":"20055","DOI":"10.1073\/pnas.0708574104","article-title":"Trafficking-dependent phosphorylation of Kv1.2 regulates voltage-gated potassium channel cell surface expression","volume":"104","author":"Yang","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B253","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1091\/mbc.e03-11-0788","article-title":"Endocytosis as a mechanism for tyrosine kinase-dependent suppression of a voltage-gated potassium channel","volume":"15","author":"Nesti","year":"2004","journal-title":"Mol Biol Cell."},{"key":"B254","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/j.1471-4159.2010.06863.x","article-title":"Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor","volume":"114","author":"Cao","year":"2010","journal-title":"J Neurochem."},{"key":"B255","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0169-328X(02)00388-1","article-title":"Downregulation of voltage-gated potassium channel alpha gene expression in dorsal root ganglia following chronic constriction injury of the rat sciatic nerve","volume":"105","author":"Kim","year":"2002","journal-title":"Brain Res Mol Brain Res."},{"key":"B256","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.neuron.2012.12.035","article-title":"Kv1.1 channels act as mechanical brake in the senses of touch and pain","volume":"77","author":"Hao","year":"2013","journal-title":"Neuron."},{"key":"B257","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1016\/j.bmc.2007.12.031","article-title":"Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators)","volume":"16","author":"Lu","year":"2008","journal-title":"Bioorg Med Chem."},{"key":"B258","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/jnc.15117","article-title":"Epigenetic restoration of voltage-gated potassium channel Kv1.2 alleviates nerve injury-induced neuropathic pain","volume":"156","author":"Zhang","year":"2021","journal-title":"J Neurochem"},{"key":"B259","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nn.3438","article-title":"A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons","volume":"16","author":"Zhao","year":"2013","journal-title":"Nat Neurosci."},{"key":"B260","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1523\/JNEUROSCI.0695-19.2019","article-title":"Contribution of DNMT1 to neuropathic pain genesis partially through epigenetically repressing Kcna2 in primary afferent neurons","volume":"39","author":"Sun","year":"2019","journal-title":"J Neurosci."},{"key":"B261","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1744-8069-10-8","article-title":"Impaired neuropathic pain and preserved acute pain in rats overexpressing voltage-gated potassium channel subunit Kv1.2 in primary afferent neurons","volume":"10","author":"Fan","year":"2014","journal-title":"Mol Pain."},{"key":"B262","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/(SICI)1097-4598(199904)22:4<502::AID-MUS12>3.0.CO;2-K","article-title":"Changes in expression of voltage-gated potassium channels in dorsal root ganglion neurons following axotomy","volume":"22","author":"Ishikawa","year":"1999","journal-title":"Muscle Nerve."},{"key":"B263","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.neuroscience.2019.03.033","article-title":"HDAC2, but not HDAC1, regulates Kv1.2 expression to mediate neuropathic pain in CCI rats","volume":"408","author":"Li","year":"2019","journal-title":"Neuroscience."},{"key":"B264","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12974-020-01901-6","article-title":"NF-kappaB p65-dependent transcriptional regulation of histone deacetylase 2 contributes to the chronic constriction injury-induced neuropathic pain via the microRNA-183\/TXNIP\/NLRP3 axis","volume":"17","author":"Miao","year":"2020","journal-title":"J Neuroinflamm."},{"key":"B265","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fncel.2014.00217","article-title":"Expression of DNA methyltransferases in adult dorsal root ganglia is cell-type specific and up regulated in a rodent model of neuropathic pain","volume":"8","author":"Pollema-Mays","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"B266","doi-asserted-by":"publisher","first-page":"9883","DOI":"10.1523\/JNEUROSCI.0880-18.2018","article-title":"MBD1 contributes to the genesis of acute pain and neuropathic pain by epigenetic silencing of Oprm1 and Kcna2 genes in primary sensory neurons","volume":"38","author":"Mo","year":"2018","journal-title":"J Neurosci."},{"key":"B267","doi-asserted-by":"publisher","first-page":"14712","DOI":"10.1038\/ncomms14712","article-title":"DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons","volume":"8","author":"Zhao","year":"2017","journal-title":"Nat Commun."},{"key":"B268","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s13311-018-00689-x","article-title":"TET1 overexpression mitigates neuropathic pain through rescuing the expression of ++-opioid receptor and Kv1.2 in the primary sensory neurons","volume":"16","author":"Wu","year":"2019","journal-title":"Neurotherapeutics."},{"key":"B269","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.expneurol.2013.11.011","article-title":"Kv2 dysfunction after peripheral axotomy enhances sensory neuron responsiveness to sustained input","volume":"251","author":"Tsantoulas","year":"2014","journal-title":"Exp Neurol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"17502","DOI":"10.1523\/JNEUROSCI.3561-12.2012","article-title":"Sensory neuron downregulation of the Kv9.1 potassium channel subunit mediates neuropathic pain following nerve injury","volume":"32","author":"Tsantoulas","year":"2012","journal-title":"J Neurosci."},{"key":"B271","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1073\/pnas.0500468102","article-title":"Fluorescence measurements reveal stoichiometry of K+ channels formed by modulatory and delayed rectifier alpha-subunits","volume":"102","author":"Kerschensteiner","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B272","doi-asserted-by":"publisher","first-page":"C406","DOI":"10.1152\/ajpcell.00343.2011","article-title":"Kv3 channels contribute to the delayed rectifier current in small cultured mouse dorsal root ganglion neurons","volume":"303","author":"Bocksteins","year":"2012","journal-title":"Am J Physiol Cell Physiol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/j.1476-5381.2009.00111.x","article-title":"Neural KCNQ (Kv7) channels","volume":"156","author":"Brown","year":"2009","journal-title":"Br J Pharmacol."},{"key":"B274","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1113\/jphysiol.1982.sp014357","article-title":"M-currents and other potassium currents in bullfrog sympathetic neurones","volume":"330","author":"Adams","year":"1982","journal-title":"J Physiol."},{"key":"B275","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fnmol.2017.00181","article-title":"The role of Kv7\/M potassium channels in controlling ectopic firing in nociceptors","volume":"10","author":"Barkai","year":"2017","journal-title":"Front Mol Neurosci."},{"key":"B276","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.pain.2012.12.005","article-title":"Suppression of KCNQ\/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model","volume":"154","author":"Zheng","year":"2013","journal-title":"Pain."},{"key":"B277","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1002\/cne.23595","article-title":"Kv7.2 regulates the function of peripheral sensory neurons","volume":"522","author":"King","year":"2014","journal-title":"J Comp Neurol."},{"key":"B278","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0014-2999(02)02924-2","article-title":"The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain","volume":"460","author":"Blackburn-Munro","year":"2003","journal-title":"Eur J Pharmacol."},{"key":"B279","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1080\/1061186X.2019.1608552","article-title":"Activation of Kv7 channels with the anticonvulsant retigabine alleviates neuropathic pain behaviour in the streptozotocin rat model of diabetic neuropathy","volume":"27","author":"Djouhri","year":"2019","journal-title":"J Drug Target."},{"key":"B280","first-page":"1","volume-title":"Kv7 Channels and Excitability Disorders","author":"Jones","year":"2021"},{"key":"B281","doi-asserted-by":"publisher","first-page":"1744806919864256","DOI":"10.1177\/1744806919864256","article-title":"Neuropathic pain and Ksbv\/s7 voltage-gated potassium channels: the potential role of Ksbv\/s7 activators in the treatment of neuropathic pain","volume":"15","author":"Abd-Elsayed","year":"2019","journal-title":"Mol Pain."},{"key":"B282","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1146\/annurev-pharmtox-010617-052912","article-title":"KCNQ-encoded potassium channels as therapeutic targets","volume":"58","author":"Barrese","year":"2018","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B283","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/neuro.02.010.2009","article-title":"Enhancing m currents: a way out for neuropathic pain?","volume":"2","author":"Rivera-Arconada","year":"2009","journal-title":"Front Mol Neurosci."},{"key":"B284","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2174\/1570159X113119990042","article-title":"Potassium channels in peripheral pain pathways: expression, function and therapeutic potential","volume":"11","author":"Du","year":"2013","journal-title":"Curr Neuropharmacol."},{"key":"B285","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1111\/bph.13978","article-title":"M-type K(+) channels in peripheral nociceptive pathways","volume":"175","author":"Du","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B286","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/j.pain.0000000000001523","article-title":"Platelet-derived growth factor activates nociceptive neurons by inhibiting M-current and contributes to inflammatory pain","volume":"160","author":"Barkai","year":"2019","journal-title":"Pain."},{"key":"B287","doi-asserted-by":"publisher","first-page":"13235","DOI":"10.1523\/JNEUROSCI.1981-10.2010","article-title":"Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability","volume":"30","author":"Mucha","year":"2010","journal-title":"J Neurosci."},{"key":"B288","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1097\/j.pain.0000000000001633","article-title":"Repressor element 1-silencing transcription factor drives the development of chronic pain states","volume":"160","author":"Zhang","year":"2019","journal-title":"Pain."},{"key":"B289","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrg2100","article-title":"Chromatin crosstalk in development and disease: lessons from REST","volume":"8","author":"Ooi","year":"2007","journal-title":"Nat Rev Genet."},{"key":"B290","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neulet.2015.12.003","article-title":"Selective repression of gene expression in neuropathic pain by the neuron-restrictive silencing factor\/repressor element-1 silencing transcription (NRSF\/REST)","volume":"625","author":"Willis","year":"2016","journal-title":"Neurosci Lett."},{"key":"B291","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s12325-020-01379-x","article-title":"The promise for histone methyltransferase inhibitors for epigenetic therapy in clinical oncology: a narrative review","volume":"37","author":"Rugo","year":"2020","journal-title":"Adv Ther."},{"key":"B292","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/19336950.2015.1056949","article-title":"Kv3.4 channel function and dysfunction in nociceptors","volume":"9","author":"Ritter","year":"2015","journal-title":"Channels."},{"key":"B293","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2337\/db10-1507","article-title":"Diabetic visceral hypersensitivity is associated with activation of mitogen-activated kinase in rat dorsal root ganglia","volume":"60","author":"Grabauskas","year":"2011","journal-title":"Diabetes."},{"key":"B294","doi-asserted-by":"publisher","first-page":"1744806919841196","DOI":"10.1177\/1744806919841196","article-title":"Spinal glial cell line-derived neurotrophic factor infusion reverses reduction of Kv4.1-mediated A-type potassium currents of injured myelinated primary afferent neurons in a neuropathic pain model","volume":"15","author":"Shinoda","year":"2019","journal-title":"Mol Pain."},{"key":"B295","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.pain.2011.11.020","article-title":"Targeting A-type K(+) channels in primary sensory neurons for bone cancer pain in a rat model","volume":"153","author":"Duan","year":"2012","journal-title":"Pain."},{"key":"B296","doi-asserted-by":"publisher","first-page":"16079","DOI":"10.1038\/ncomms16079","article-title":"MicroRNA cluster miR-17-92 regulates multiple functionally related voltage-gated potassium channels in chronic neuropathic pain","volume":"8","author":"Sakai","year":"2017","journal-title":"Nat Commun."},{"key":"B297","doi-asserted-by":"publisher","first-page":"9855","DOI":"10.1523\/JNEUROSCI.0604-07.2007","article-title":"Reduced expression of A-type potassium channels in primary sensory neurons induces mechanical hypersensitivity","volume":"27","author":"Chien","year":"2007","journal-title":"J Neurosci."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1523\/JNEUROSCI.1594-14.2015","article-title":"Dysregulation of Kv3.4 channels in dorsal root ganglia following spinal cord injury","volume":"35","author":"Ritter","year":"2015","journal-title":"J Neurosci."},{"key":"B299","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1523\/JNEUROSCI.1619-16.2017","article-title":"K(+) channel modulatory subunits KChIP and DPP participate in Kv4-mediated mechanical pain control","volume":"37","author":"Kuo","year":"2017","journal-title":"J Neurosci."},{"key":"B300","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1152\/jn.00054.2014","article-title":"Differential contribution of Kv4-containing channels to A-type, voltage-gated potassium currents in somatic and visceral dorsal root ganglion neurons","volume":"112","author":"Yunoki","year":"2014","journal-title":"J Neurophysiol."},{"key":"B301","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.lfs.2012.07.007","article-title":"Distinct cellular distributions of Kv4 pore-forming and auxiliary subunits in rat dorsal root ganglion neurons","volume":"91","author":"Matsuyoshi","year":"2012","journal-title":"Life Sci."},{"key":"B302","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2009.12.021","article-title":"Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury","volume":"166","author":"Uchida","year":"2016","journal-title":"Neuroscience."},{"key":"B303","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1113\/jphysiol.2007.150540","article-title":"Ternary Kv4.2 channels recapitulate voltage-dependent inactivation kinetics of A-type K+ channels in cerebellar granule neurons","volume":"586","author":"Amarillo","year":"2008","journal-title":"J Physiol."},{"key":"B304","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1152\/physrev.00020.2009","article-title":"Ancillary subunits associated with voltage-dependent K+ channels","volume":"90","author":"Pongs","year":"2010","journal-title":"Physiol Rev."},{"key":"B305","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4161\/chan.3.6.10216","article-title":"A novel N-terminal motif of dipeptidyl peptidase-like proteins produces rapid inactivation of KV4.2 channels by a pore-blocking mechanism","volume":"3","author":"Jerng","year":"2009","journal-title":"Channels."},{"key":"B306","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0306-4522(98)00443-6","article-title":"Nerve injury increases an excitatory action of neuropeptide Y and Y2- agonists on dorsal root ganglion neurons","volume":"89","author":"Abdulla","year":"1999","journal-title":"Neuroscience."},{"key":"B307","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/jcp.21007","article-title":"Characterization of voltage-and Ca2+-activated K+ channels in rat dorsal root ganglion neurons","volume":"212","author":"Li","year":"2007","journal-title":"J Cell Physiol."},{"key":"B308","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1460-9568.2009.07060.x","article-title":"BKCa currents are enriched in a subpopulation of adult rat cutaneous nociceptive dorsal root ganglion neurons","volume":"31","author":"Zhang","year":"2010","journal-title":"Eur J Neurosci."},{"key":"B309","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainres.2006.11.055","article-title":"Opposing effects of spinal nerve ligation on calcium-activated potassium currents in axotomized and adjacent mammalian primary afferent neurons","volume":"1132","author":"Sarantopoulos","year":"2007","journal-title":"Brain Res."},{"key":"B310","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1471-4159.2009.06138.x","article-title":"Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain","volume":"110","author":"Chen","year":"2009","journal-title":"J Neurochem."},{"key":"B311","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.celrep.2018.01.073","article-title":"BK potassium channels suppress Cavalpha2delta subunit function to reduce inflammatory and neuropathic pain","volume":"22","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"B312","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/cmdc.201200321","article-title":"Structure-activity relationships of a novel group of large-conductance Ca(2+)-activated K(+) (BK) channel modulators: the GoSlo-SR family","volume":"7","author":"Roy","year":"2012","journal-title":"ChemMedChem."},{"key":"B313","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ejphar.2011.08.013","article-title":"Large conductance Ca2+ -activated K+ channel activation with NS1619 decreases myogenic and neurogenic contractions of rat detrusor smooth muscle","volume":"670","author":"Soder","year":"2011","journal-title":"Eur J Pharmacol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s00424-003-1012-4","article-title":"BK channel openers inhibit migration of human glioma cells","volume":"446","author":"Kraft","year":"2003","journal-title":"Pflugers Arch."},{"key":"B315","doi-asserted-by":"publisher","first-page":"R378","DOI":"10.1152\/ajpregu.00458.2009","article-title":"BK channel activation by NS11021 decreases excitability and contractility of urinary bladder smooth muscle","volume":"298","author":"Layne","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B316","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1124\/mol.107.038331","article-title":"The small molecule NS11021 is a potent and specific activator of Ca2+-activated big-conductance K+ channels","volume":"72","author":"Bentzen","year":"2007","journal-title":"Mol Pharmacol."},{"key":"B317","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00210-009-0456-2","article-title":"Synthesis and characterisation of NS13558: a new important tool for addressing KCa1.1 channel function ex vivo","volume":"381","author":"Bentzen","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B318","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1124\/jpet.105.093856","article-title":"Molecular mechanisms for large conductance Ca2+-activated K+ channel activation by a novel opener, 12,14-dichlorodehydroabietic acid","volume":"316","author":"Sakamoto","year":"2006","journal-title":"J Pharmacol Exp Ther."},{"key":"B319","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.neuropharm.2017.08.021","article-title":"KCa3.1 channels modulate the processing of noxious chemical stimuli in mice","volume":"125","author":"Lu","year":"2017","journal-title":"Neuropharmacology."},{"key":"B320","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/JPR.S274563","article-title":"A KCa3.1 channel opener, ASP0819, modulates nociceptive signal processing from peripheral nerves in fibromyalgia-like pain in rats","volume":"14","author":"Takeshita","year":"2021","journal-title":"J Pain Res."},{"key":"B321","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.2147\/JPR.S274562","article-title":"Efficacy and safety of ASP0819 in patients with fibromyalgia: results of a proof-of-concept, randomized, double-blind, placebo-controlled trial","volume":"13","author":"Arnold","year":"2020","journal-title":"J Pain Res."},{"key":"B322","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1744-8069-6-6","article-title":"KATP channel subunits in rat dorsal root ganglia: alterations by painful axotomy","volume":"6","author":"Zoga","year":"2010","journal-title":"Mol Pain."},{"key":"B323","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuroscience.2009.04.076","article-title":"ATP-sensitive potassium currents in rat primary afferent neurons: biophysical, pharmacological properties, and alterations by painful nerve injury","volume":"162","author":"Kawano","year":"2009","journal-title":"Neuroscience."},{"key":"B324","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/sj.embor.7400003","article-title":"Potassium channel regulation","volume":"4","author":"Campbell","year":"2003","journal-title":"EMBO Rep."},{"key":"B325","first-page":"390","article-title":"Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?","volume":"267","author":"Welch","year":"1993","journal-title":"J Pharmacol Exp Ther."},{"key":"B326","doi-asserted-by":"publisher","first-page":"8725","DOI":"10.1073\/pnas.0901815106","article-title":"Suppressed Ca2+\/CaM\/CaMKII-dependent K(ATP) channel activity in primary afferent neurons mediates hyperalgesia after axotomy","volume":"106","author":"Kawano","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B327","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/bph.14518","article-title":"Two-pore domain potassium channels: emerging targets for novel analgesic drugs: IUPHAR review 26","volume":"176","author":"Gada","year":"2019","journal-title":"Br J Pharmacol."},{"key":"B328","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1113\/jphysiol.2007.145649","article-title":"TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones","volume":"585","author":"Dobler","year":"2007","journal-title":"J Physiol."},{"key":"B329","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1744-8069-7-30","article-title":"TRESK channel contribution to nociceptive sensory neurons excitability: modulation by nerve injury","volume":"7","author":"Tulleuda","year":"2011","journal-title":"Mol Pain."},{"key":"B330","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1113\/JP279203","article-title":"TRESK background K+ channel deletion selectively uncovers enhanced mechanical and cold sensitivity","volume":"598","author":"Castellanos","year":"2020","journal-title":"J Physiol."},{"key":"B331","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2013.08.002","article-title":"Expression of background potassium channels in rat DRG is cell-specific and down-regulated in a neuropathic pain model","volume":"57","author":"Pollema-Mays","year":"2013","journal-title":"Mol Cell Neurosci."},{"key":"B332","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00232-021-00189-8","article-title":"Two-pore domain potassium channel in neurological disorders","volume":"254","author":"Singh","year":"2021","journal-title":"J Membr Biol"},{"key":"B333","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/bph.14098","article-title":"GI-530159, a novel, selective, mechanosensitive two-pore-domain potassium (K2P) channel opener, reduces rat dorsal root ganglion neuron excitability","volume":"175","author":"Loucif","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B334","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1111\/bph.13906","article-title":"Recent advances in the development of T-type calcium channel blockers for pain intervention","volume":"175","author":"Snutch","year":"2017","journal-title":"Br J Pharmacol."},{"key":"B335","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.tips.2016.05.002","article-title":"Voltage-gated ion channels in the PNS: novel therapies for neuropathic pain?","volume":"37","author":"Tibbs","year":"2016","journal-title":"Trends Pharmacol Sci."},{"key":"B336","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","article-title":"International Union of Pharmacology. XLVIII Nomenclature and structure-function relationships of voltage-gated calcium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol Rev."},{"key":"B337","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1113\/JP272262","article-title":"Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology","volume":"594","author":"Dolphin","year":"2016","journal-title":"J Physiol."},{"key":"B338","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1152\/jn.00069.2013","article-title":"Identification of CaV channel types expressed in muscle afferent neurons","volume":"110","author":"Ramachandra","year":"2013","journal-title":"J Neurophysiol."},{"key":"B339","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.5","article-title":"Targeting voltage-gated calcium channels in neurological and psychiatric diseases","author":"Zamponi","year":"2015","journal-title":"Nat Rev Drug Discov."},{"key":"B340","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1152\/physrev.00023.2013","article-title":"Calcium-permeable ion channels in pain signaling","volume":"94","author":"Bourinet","year":"2014","journal-title":"Physiol Rev."},{"key":"B341","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1097\/j.pain.0000000000000612","article-title":"Thrombospondin-4 divergently regulates voltage-gated Ca2+ channel subtypes in sensory neurons after nerve injury","volume":"157","author":"Pan","year":"2016","journal-title":"Pain."},{"key":"B342","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1152\/jn.2000.83.4.2227","article-title":"Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons","volume":"83","author":"Baccei","year":"2000","journal-title":"J Neurophysiol."},{"key":"B343","first-page":"1117","article-title":"Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia","volume":"269","author":"Chaplan","year":"1994","journal-title":"J Pharmacol Exp Ther."},{"key":"B344","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1111\/bph.13789","article-title":"Calcium channel modulation as a target in chronic pain control","volume":"175","author":"Patel","year":"2018","journal-title":"Br J Pharmacol."},{"key":"B345","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.0409066103","article-title":"Identification of the {alpha}2-{delta}-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin","volume":"103","author":"Field","year":"2006","journal-title":"PNAS."},{"key":"B346","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nrn3311","article-title":"Calcium channel auxiliary alpha2delta and beta subunits: trafficking and one step beyond","volume":"13","author":"Dolphin","year":"2012","journal-title":"Nat Rev Neurosci."},{"key":"B347","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1093\/emboj\/20.10.2349","article-title":"Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel","volume":"20","author":"Saegusa","year":"2001","journal-title":"EMBO J."},{"key":"B348","doi-asserted-by":"publisher","first-page":"1744806918765806","DOI":"10.1177\/1744806918765806","article-title":"Peripheral nerve injury increases contribution of L-type calcium channels to synaptic transmission in spinal lamina II: role of alpha2delta-1 subunits","volume":"14","author":"Alles","year":"2018","journal-title":"Mol Pain."},{"key":"B349","doi-asserted-by":"publisher","first-page":"16412","DOI":"10.1523\/JNEUROSCI.1026-13.2013","article-title":"\u03b12\u03b4-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage","volume":"33","author":"Patel","year":"2013","journal-title":"J Neurosci."},{"key":"B350","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1152\/jn.1992.67.3.561","article-title":"Heterogeneous calcium currents and transmitter release in cultured mouse spinal cord and dorsal root ganglion neurons","volume":"67","author":"Yu","year":"1992","journal-title":"J Neurophysiol."},{"key":"B351","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0304-3959(99)00313-9","article-title":"Painful neuropathy decreases membrane calcium current in mammalian primary afferent neurons","volume":"86","author":"Hogan","year":"2000","journal-title":"Pain."},{"key":"B352","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1523\/JNEUROSCI.3145-09.2010","article-title":"Knockdown of L calcium channel subtypes: differential effects in neuropathic pain","volume":"30","author":"Fossat","year":"2010","journal-title":"J Neurosci."},{"key":"B353","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1113\/JP272725","article-title":"Cav1.2 and Cav1.3 L-type calcium channels independently control short- and long-term sensitization to pain","volume":"594","author":"Radwani","year":"2016","journal-title":"J Physiol."},{"key":"B354","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1085\/jgp.201611586","article-title":"The alpha2delta-1 subunit remodels CaV1.2 voltage sensors and allows Ca2+ influx at physiological membrane potentials","volume":"148","author":"Savalli","year":"2016","journal-title":"J Gen Physiol."},{"key":"B355","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0303-8467(96)00594-X","article-title":"Complex regional pain syndrome (reflex sympathetic dystrophy and causalgia): management with the calcium channel blocker nifedipine and\/or the alpha-sympathetic blocker phenoxybenzamine in 59 patients","volume":"99","author":"Muizelaar","year":"1997","journal-title":"Clin Neurol Neurosurg."},{"key":"B356","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002465","article-title":"Voltage gated calcium channels in human dorsal root ganglion neurons","author":"Hartung","year":"2021","journal-title":"Pain."},{"key":"B357","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00424-014-1566-3","article-title":"1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain","volume":"467","author":"Bladen","year":"2015","journal-title":"Pflugers Arch."},{"key":"B358","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s00424-015-1725-1","article-title":"Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels","volume":"467","author":"Gadotti","year":"2015","journal-title":"Pflugers Arch."},{"key":"B359","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1523\/JNEUROSCI.18-16-06319.1998","article-title":"Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals","volume":"18","author":"Westenbroek","year":"1998","journal-title":"J Neurosci."},{"key":"B360","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1073\/pnas.93.14.7363","article-title":"Isoform-specific interaction of the alpha1A subunits of brain Ca2+ channels with the presynaptic proteins syntaxin and SNAP-25","volume":"93","author":"Rettig","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B361","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/379451a0","article-title":"Calcium-dependent interaction of N-type calcium channels with the synaptic core complex","volume":"379","author":"Sheng","year":"1996","journal-title":"Nature."},{"key":"B362","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.2174\/0929867043363884","article-title":"Ziconotide: neuronal calcium channel blocker for treating severe chronic pain","volume":"11","author":"Miljanich","year":"2004","journal-title":"Curr Med Chem."},{"key":"B363","doi-asserted-by":"publisher","first-page":"e02055","DOI":"10.1002\/brb3.2055","article-title":"Intrathecal pain management with ziconotide: time for consensus?","author":"Matis","year":"2021","journal-title":"Brain Behav."},{"key":"B364","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jpain.2013.12.002","article-title":"Mechanistic insights into the analgesic efficacy of A-1264087, a novel neuronal Ca(2+) channel blocker that reduces nociception in rat preclinical pain models","volume":"15","author":"Zhu","year":"2014","journal-title":"J Pain."},{"key":"B365","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1124\/mol.111.075226","article-title":"Characterization of the substituted N-triazole oxindole TROX-1, a small-molecule, state-dependent inhibitor of Ca(V)2 calcium channels","volume":"81","author":"Swensen","year":"2012","journal-title":"Mol Pharmacol."},{"key":"B366","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1016\/j.bmc.2015.05.053","article-title":"Discovery of an 8-methoxytetrahydroisoquinoline derivative as an orally active N-type calcium channel blocker for neuropathic pain without CYP inhibition liability","volume":"23","author":"Ogiyama","year":"2015","journal-title":"Bioorg Med Chem."},{"key":"B367","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1016\/j.bmc.2015.05.030","article-title":"Discovery of a 1-isopropyltetrahydroisoquinoline derivative as an orally active N-type calcium channel blocker for neuropathic pain","volume":"23","author":"Ogiyama","year":"2015","journal-title":"Bioorg Med Chem."},{"key":"B368","doi-asserted-by":"publisher","first-page":"31375","DOI":"10.1074\/jbc.M109.009951","article-title":"An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels","volume":"284","author":"Brittain","year":"2009","journal-title":"J Biol Chem."},{"key":"B369","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1097\/j.pain.0000000000000628","article-title":"Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential","volume":"157","author":"Xie","year":"2016","journal-title":"Pain."},{"key":"B370","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1124\/pr.55.4.3","article-title":"G protein modulation of voltage-gated calcium channels","volume":"55","author":"Dolphin","year":"2003","journal-title":"Pharmacol Rev."},{"key":"B371","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0304-3940(91)90569-F","article-title":"Intrathecal administration of clonidine suppresses autotomy, a behavioral sign of chronic pain in rats after sciatic nerve section","volume":"133","author":"Puke","year":"1991","journal-title":"Neurosci Lett."},{"key":"B372","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth Prog."},{"key":"B373","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/cne.20899","article-title":"Sympathetic sprouting and changes in nociceptive sensory innervation in the glabrous skin of the rat hind paw following partial peripheral nerve injury","volume":"495","author":"Yen","year":"2006","journal-title":"J Comp Neurol."},{"key":"B374","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/BST0380525","article-title":"The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo","volume":"38","author":"Bauer","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"B375","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrd1756","article-title":"Pregabalin","volume":"4","author":"Dworkin","year":"2005","journal-title":"Nat Rev Drug Discov."},{"key":"B376","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/jpet.104.067934","article-title":"XP13512 [(+\/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters","volume":"311","author":"Cundy","year":"2004","journal-title":"J Pharmacol Exp Ther."},{"key":"B377","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.neulet.2014.07.033","article-title":"Suppression of network activity in dorsal horn by gabapentin permeation of TRPV1 channels; implications for drug access to cytoplasmic targets","volume":"584","author":"Biggs","year":"2015","journal-title":"Neurosci Lett."},{"key":"B378","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1210\/er.2005-0888","article-title":"The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology","volume":"27","author":"Yang","year":"2006","journal-title":"Endocr Rev."},{"key":"B379","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbrc.2014.05.103","article-title":"N-type voltage-dependent Ca2+ channel in non-excitable microglial cells in mice is involved in the pathophysiology of neuropathic pain","volume":"450","author":"Saegusa","year":"2014","journal-title":"Biochem Biophys Res Commun."},{"key":"B380","doi-asserted-by":"publisher","first-page":"102059","DOI":"10.1016\/j.ceca.2019.102059","article-title":"Involvement of N-type Ca(2+) channel in microglial activation and its implications to aging-induced exaggerated cytokine response","volume":"82","author":"Huntula","year":"2019","journal-title":"Cell Calcium."},{"key":"B381","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13041-021-00813-7","article-title":"Modeling temperature- and Cav3 subtype-dependent alterations in T-type calcium channel mediated burst firing","volume":"14","author":"Fernandez","year":"2021","journal-title":"Mol Brain."},{"key":"B382","doi-asserted-by":"publisher","first-page":"9374","DOI":"10.1523\/JNEUROSCI.0068-12.2012","article-title":"Presynaptic CaV3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons","volume":"32","author":"Jacus","year":"2012","journal-title":"J Neurosci."},{"key":"B383","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","article-title":"The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity","volume":"83","author":"Garcia-Caballero","year":"2014","journal-title":"Neuron."},{"key":"B384","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1074\/jbc.M111.290882","article-title":"A Ca(v)3.2\/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis","volume":"287","author":"Weiss","year":"2012","journal-title":"J Biol Chem."},{"key":"B385","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuroscience.2013.07.005","article-title":"Immunohistological demonstration of CaV3.2 T-type voltage-gated calcium channel expression in soma of dorsal root ganglion neurons and peripheral axons of rat and mouse","volume":"250","author":"Rose","year":"2013","journal-title":"Neuroscience."},{"key":"B386","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1523\/JNEUROSCI.19-06-01895.1999","article-title":"Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels","volume":"19","author":"Talley","year":"1999","journal-title":"J Neurosci."},{"key":"B387","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.tips.2004.07.004","article-title":"Targeting Ca2+ channels to treat pain: T-type versus N-type","volume":"25","author":"Altier","year":"2004","journal-title":"Trends Pharmacol Sci."},{"key":"B388","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1523\/JNEUROSCI.4866-06.2007","article-title":"Cell-specific alterations of t-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons","volume":"27","author":"Jagodic","year":"2007","journal-title":"J Neurosci."},{"key":"B389","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1152\/jn.01031.2007","article-title":"Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve","volume":"99","author":"Jagodic","year":"2008","journal-title":"J Neurophysiol."},{"key":"B390","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1523\/JNEUROSCI.0517-20.2020","article-title":"Contribution of T-type calcium channels to spinal cord injury-induced hyperexcitability of nociceptors","volume":"40","author":"Lauzadis","year":"2020","journal-title":"J Neurosci."},{"key":"B391","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00424-014-1484-4","article-title":"T-type calcium channels in chronic pain: mouse models and specific blockers","volume":"466","author":"Francois","year":"2014","journal-title":"Pflugers Arch."},{"key":"B392","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00424-012-1211-y","article-title":"Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling","volume":"465","author":"Todorovic","year":"2013","journal-title":"Pflugers Arch."},{"key":"B393","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00424-014-1452-z","article-title":"Targeting of CaV3","volume":"466","author":"Todorovic","year":"2014","journal-title":"Pflugers Arch."},{"key":"B394","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.celrep.2014.12.042","article-title":"The low-threshold calcium channel Cav3.2 determines low-threshold mechanoreceptor function","volume":"10","author":"Francois","year":"2015","journal-title":"Cell Rep."},{"key":"B395","doi-asserted-by":"publisher","first-page":"1744806917724698","DOI":"10.1177\/1744806917724698","article-title":"Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3. 2\u2013USP5 interactions in the pain pathway","volume":"13","author":"Stemkowski","year":"2017","journal-title":"Mol Pain."},{"key":"B396","doi-asserted-by":"publisher","first-page":"173587","DOI":"10.1016\/j.ejphar.2020.173587","article-title":"Cav3.2 overexpression in L4 dorsal root ganglion neurons after L5 spinal nerve cutting involves Egr-1, USP5 and HMGB1 in rats: an emerging signaling pathway for neuropathic pain","volume":"888","author":"Tomita","year":"2020","journal-title":"Eur J Pharmacol."},{"key":"B397","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00424-013-1259-3","article-title":"Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation","volume":"465","author":"Weiss","year":"2013","journal-title":"Pflugers Arch."},{"key":"B398","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.2337\/db13-0813","article-title":"Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels","volume":"62","author":"Orestes","year":"2013","journal-title":"Diabetes."},{"key":"B399","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/scisignal.aaw2300","article-title":"Brain-derived neurotrophic factor stimulation of T-type Ca(2+) channels in sensory neurons contributes to increased peripheral pain sensitivity","volume":"12","author":"Wang","year":"2019","journal-title":"Sci Signal."},{"key":"B400","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1152\/jn.00839.2018","article-title":"Receptor dependence of BDNF actions in superficial dorsal horn: relation to central sensitization and actions of macrophage colony stimulating factor 1","volume":"121","author":"Boakye","year":"2019","journal-title":"J Neurophysiol."},{"key":"B401","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neuroscience.2014.05.044","article-title":"BDNF: no gain without pain?","volume":"283","author":"Smith","year":"2014","journal-title":"Neuroscience."},{"key":"B402","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-021-02631-1","article-title":"Regulation of CaV3.2 channels by the receptor for activated C kinase 1 (Rack-1)","author":"Gandini","year":"2021","journal-title":"Pflugers Archiv Euro J Physiol"},{"key":"B403","doi-asserted-by":"publisher","first-page":"134477","DOI":"10.1016\/j.neulet.2019.134477","article-title":"Receptor for activated C kinase 1 mediates the chronic constriction injury-induced neuropathic pain in the rats' peripheral and central nervous system","volume":"712","author":"Lu","year":"2019","journal-title":"Neurosci Lett."},{"key":"B404","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0304-3959(03)00177-5","article-title":"Reversal of experimental neuropathic pain by T-type calcium channel blockers","volume":"105","author":"Dogrul","year":"2003","journal-title":"Pain."},{"key":"B405","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00424-015-1733-1","article-title":"Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain","volume":"468","author":"M'Dahoma","year":"2015","journal-title":"Pflugers Arch"},{"key":"B406","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1021\/acsmedchemlett.5b00023","article-title":"Optimization of ADME properties for sulfonamides leading to the discovery of a T-type calcium channel blocker, ABT-639","volume":"6","author":"Zhang","year":"2015","journal-title":"ACS Med Chem Lett."},{"key":"B407","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bcp.2014.03.015","article-title":"A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats","volume":"89","author":"Jarvis","year":"2014","journal-title":"Biochem Pharmacol."},{"key":"B408","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1097\/j.pain.0000000000000263","article-title":"A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain","volume":"156","author":"Ziegler","year":"2015","journal-title":"Pain."},{"key":"B409","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1124\/mol.111.073205","article-title":"TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent","volume":"80","author":"Choe","year":"2011","journal-title":"Mol Pharmacol."},{"key":"B410","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pain.2012.10.023","article-title":"State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects","volume":"154","author":"Francois","year":"2013","journal-title":"Pain."},{"key":"B411","doi-asserted-by":"publisher","first-page":"121ra19","DOI":"10.1126\/scitranslmed.3003120","article-title":"T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures","volume":"4","author":"Tringham","year":"2012","journal-title":"Sci Transl Med."},{"key":"B412","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1111\/bph.15498","article-title":"The T-type calcium channel antagonist, Z944, reduces spinal excitability and pain hypersensitivity","volume":"178","author":"Harding","year":"2021","journal-title":"Br J Pharmacol."},{"key":"B413","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainresrev.2008.12.021","article-title":"Role of voltage-gated calcium channels in ascending pain pathways","volume":"60","author":"Zamponi","year":"2009","journal-title":"Brain Res Rev."},{"key":"B414","doi-asserted-by":"publisher","first-page":"9769","DOI":"10.1021\/acs.jmedchem.7b01236","article-title":"Discovery of a potent, selective T-type calcium channel blocker as a drug candidate for the treatment of generalized epilepsies","volume":"60","author":"Bezencon","year":"2017","journal-title":"J Med Chem."},{"key":"B415","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1744-8069-10-77","article-title":"NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors","volume":"10","author":"Berger","year":"2014","journal-title":"Mol Pain."},{"key":"B416","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1124\/pr.57.4.8","article-title":"International Union of Pharmacology. LI Nomenclature and structure-function relationships of cyclic nucleotide-regulated channels","volume":"57","author":"Hofmann","year":"2005","journal-title":"Pharmacol Rev."},{"key":"B417","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuroscience.2015.03.041","article-title":"Increased expression of HCN2 channel protein in L4 dorsal root ganglion neurons following axotomy of L5- and inflammation of L4-spinal nerves in rats","volume":"295","author":"Smith","year":"2015","journal-title":"Neuroscience."},{"key":"B418","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.pain.2014.05.021","article-title":"Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels","volume":"155","author":"Young","year":"2014","journal-title":"Pain."},{"key":"B419","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.tips.2012.04.004","article-title":"HCN2 ion channels: an emerging role as the pacemakers of pain","volume":"33","author":"Emery","year":"2012","journal-title":"Trends Pharmacol Sci."},{"key":"B420","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1126\/science.1206243","article-title":"HCN2 ion channels play a central role in inflammatory and neuropathic pain","volume":"333","author":"Emery","year":"2011","journal-title":"Science."},{"key":"B421","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.neuroscience.2006.10.048","article-title":"Role of peripheral hyperpolarization-activated cyclic nucleotide-modulated channel pacemaker channels in acute and chronic pain models in the rat","volume":"144","author":"Luo","year":"2007","journal-title":"Neuroscience."},{"key":"B422","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1460-9568.2004.03235.x","article-title":"Expression of hyperpolarization-activated and cyclic nucleotide-gated cation channel subunit 2 in axon terminals of peptidergic nociceptive primary sensory neurons in the superficial spinal dorsal horn of rats","volume":"19","author":"Antal","year":"2004","journal-title":"Eur J Neurosci."},{"key":"B423","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1460-9568.2006.05013.x","article-title":"Hyperpolarization-activated and cyclic nucleotide-gated cation channel subunit 2 ion channels modulate synaptic transmission from nociceptive primary afferents containing substance P to secondary sensory neurons in laminae I-IIo of the rodent spinal dorsal horn","volume":"24","author":"Papp","year":"2006","journal-title":"Eur J Neurosci."},{"key":"B424","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1523\/JNEUROSCI.23-04-01169.2003","article-title":"Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain","volume":"23","author":"Chaplan","year":"2003","journal-title":"J Neurosci."},{"key":"B425","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/j.1532-2149.2014.00460.x","article-title":"The heart-rate-reducing agent, ivabradine, reduces mechanical allodynia in a rodent model of neuropathic pain","volume":"18","author":"Noh","year":"2014","journal-title":"Eur J Pain."},{"key":"B426","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3389\/fphar.2018.01252","article-title":"Selective blockade of HCN1\/HCN2 channels as a potential pharmacological strategy against pain","volume":"9","author":"Dini","year":"2018","journal-title":"Front Pharmacol."},{"key":"B427","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1113\/JP278211","article-title":"HCN3 ion channels: roles in sensory neuronal excitability and pain","volume":"597","author":"Lainez","year":"2019","journal-title":"J Physiol."},{"key":"B428","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brainresbull.2019.03.016","article-title":"Concerted suppression of Ih and activation of IK(M) by ivabradine, an HCN-channel inhibitor, in pituitary cells and hippocampal neurons","volume":"149","author":"Hsiao","year":"2019","journal-title":"Brain Res Bull."},{"key":"B429","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2016.08.021","article-title":"Inhibition of HCN channel activity in the thalamus attenuates chronic pain in rats","volume":"631","author":"Ding","year":"2016","journal-title":"Neurosci Lett."},{"key":"B430","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1097\/j.pain.0000000000001638","article-title":"A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial","volume":"160","author":"Lee","year":"2019","journal-title":"Pain."},{"key":"B431","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1124\/pr.117.014035","article-title":"The hyperpolarization-activated cyclic nucleotide-gated channels: from biophysics to pharmacology of a unique family of ion channels","volume":"69","author":"Sartiani","year":"2017","journal-title":"Pharmacol Rev."},{"key":"B432","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1021\/acs.jmedchem.8b00280","article-title":"Discovery of allosteric, potent, subtype selective, and peripherally restricted TrkA kinase inhibitors","volume":"62","author":"Bagal","year":"2019","journal-title":"J Med Chem."},{"key":"B433","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1021\/acs.jmedchem.8b00633","article-title":"Discovery of potent, selective, and peripherally restricted pan-trk kinase inhibitors for the treatment of pain","volume":"61","author":"Bagal","year":"2018","journal-title":"J Med Chem."},{"key":"B434","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/open.201800244","article-title":"Flupirtine analogues: explorative synthesis and influence of chemical structure on KV7.2\/KV7.3 channel opening activity","volume":"8","author":"Surur","year":"2019","journal-title":"Chem Open."},{"key":"B435","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pain.2009.06.012","article-title":"In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy","volume":"145","author":"Messinger","year":"2009","journal-title":"Pain."},{"key":"B436","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/CBO9781139152211.005","article-title":"An overview of animal models of neuropathic pain","volume-title":"Neuropathic Pain, Causes, Management and Understanding","author":"Stemkowski","year":"2013"},{"key":"B437","doi-asserted-by":"publisher","first-page":"102030","DOI":"10.1016\/j.pneurobio.2021.102030","article-title":"Neuropathic pain modeling: focus on synaptic and ion channel mechanisms","volume":"201","author":"Bouali-Benazzouz","year":"2021","journal-title":"Prog Neurobiol."},{"key":"B438","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrn2606","article-title":"Animal models of pain: progress and challenges","volume":"10","author":"Mogil","year":"2009","journal-title":"Nat Rev Neurosci."},{"key":"B439","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/laban.1223","article-title":"Laboratory environmental factors and pain behavior: the relevance of unknown unknowns to reproducibility and translation","volume":"46","author":"Mogil","year":"2017","journal-title":"Lab Anim."},{"key":"B440","doi-asserted-by":"publisher","first-page":"e0150164","DOI":"10.1371\/journal.pone.0150164","article-title":"Mechanical Conflict System: A Novel Operant Method for the Assessment of Nociceptive Behavior","volume":"11","author":"Harte","year":"2016","journal-title":"PLoS One."},{"key":"B441","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0270(00)00160-6","article-title":"An operant assay of thermal pain in conscious, unrestrained rats","volume":"97","author":"Mauderli","year":"2000","journal-title":"J Neurosci Methods."},{"key":"B442","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.106.106377","article-title":"Preclinical assessment of candidate analgesic drugs: recent advances and future challenges","volume":"319","author":"Negus","year":"2006","journal-title":"J Pharmacol Exp Ther."},{"key":"B443","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrn3360","article-title":"Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon","volume":"13","author":"Mogil","year":"2012","journal-title":"Nat Rev Neurosci."},{"key":"B444","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-neuro-092820-105941","article-title":"Sources of individual differences in pain","volume":"44","author":"Mogil","year":"2021","journal-title":"Ann Rev Neurosci."},{"key":"B445","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13041-017-0289-8","article-title":"Molecules in pain and sex: a developing story","volume":"10","author":"Mapplebeck","year":"2017","journal-title":"Mol Brain."},{"key":"B446","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","article-title":"Sex, gender, and pain: a review of recent clinical and experimental findings","volume":"10","author":"Fillingim","year":"2009","journal-title":"J Pain."},{"key":"B447","doi-asserted-by":"publisher","first-page":"e1009428","DOI":"10.1371\/journal.pgen.1009428","article-title":"Sex-stratified genome-wide association study of multisite chronic pain in UK Biobank","volume":"17","author":"Johnston","year":"2021","journal-title":"PLoS Genet."},{"key":"B448","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41583-020-0310-6","article-title":"Qualitative sex differences in pain processing: emerging evidence of a biased literature","volume":"21","author":"Mogil","year":"2020","journal-title":"Nat Rev Neurosci."},{"key":"B449","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cub.2018.11.030","article-title":"Male-specific conditioned pain hypersensitivity in mice and humans","volume":"29","author":"Martin","year":"2019","journal-title":"Curr Biol."},{"key":"B450","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.jpain.2012.09.009","article-title":"In vivo and in vitro comparison of female and male nociceptors","volume":"13","author":"Hendrich","year":"2012","journal-title":"J Pain."},{"key":"B451","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nn.4053","article-title":"Different immune cells mediate mechanical pain hypersensitivity in male and female mice","volume":"18","author":"Sorge","year":"2015","journal-title":"Nat Neurosci."},{"key":"B452","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/jnr.23841","article-title":"Sex differences in pain","volume":"95","author":"Sorge","year":"2016","journal-title":"J Neurosci Res."},{"key":"B453","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fcell.2021.624201","article-title":"Use of integrated optical clearing and 2-photon imaging to investigate sex differences in neuroimmune interactions after peripheral nerve injury","volume":"9","author":"Szabo-Pardi","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"B454","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jpain.2015.12.013","article-title":"Manipulation of neurotransmitter levels has differential effects on formalin-evoked nociceptive behavior in male and female mice","volume":"17","author":"Mifflin","year":"2016","journal-title":"J Pain."},{"key":"B455","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.15.447407","article-title":"Sexual dimorphism in a neuronal mechanism of spinal hyperexcitability across rodent and human models of pathological pain","author":"Dedek","year":"2021","journal-title":"BioRxiv [Preprint]."},{"key":"B456","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.neuron.2021.06.015","article-title":"IL-23\/IL-17A\/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice","volume":"109","author":"Luo","year":"2021","journal-title":"Neuron."},{"key":"B457","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/j.pain.0000000000001399","article-title":"Targeting the Nav1.8 ion channel engenders sex-specific responses in lysophosphatidic acid-induced joint neuropathy","volume":"160","author":"O'Brien","year":"2019","journal-title":"Pain."},{"key":"B458","doi-asserted-by":"publisher","first-page":"147438","DOI":"10.1016\/j.brainres.2021.147438","article-title":"Sex-dependent Cav2.3 channel contribution to the secondary hyperalgesia in a mice model of central sensitization","volume":"1764","author":"Ferreira","year":"2021","journal-title":"Brain Res."},{"key":"B459","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41593-021-00806-8","article-title":"Considering sex as a biological variable will require a global shift in science culture","volume":"24","author":"Shansky","year":"2021","journal-title":"Nat Neurosci."},{"key":"B460","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/j.pain.0000000000000753","article-title":"Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles","volume":"158","author":"Baron","year":"2017","journal-title":"Pain."},{"key":"B461","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1523\/JNEUROSCI.0029-20.2020","article-title":"Neonatal injury evokes persistent deficits in dynorphin inhibitory circuits within the adult mouse superficial dorsal horn","volume":"40","author":"Brewer","year":"2020","journal-title":"J Neurosci."},{"key":"B462","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1523\/JNEUROSCI.1786-18.2019","article-title":"Priming of adult incision response by early-life injury: neonatal microglial inhibition has persistent but sexually dimorphic effects in adult rats","volume":"39","author":"Moriarty","year":"2019","journal-title":"J Neurosci."},{"key":"B463","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/brain\/awr288","article-title":"Priming of adult pain responses by neonatal pain experience: maintenance by central neuroimmune activity","volume":"135","author":"Beggs","year":"2012","journal-title":"Brain."},{"key":"B464","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jpain.2010.11.005","article-title":"Enhanced excitability and down-regulated voltage-gated potassium channels in colonic drg neurons from neonatal maternal separation rats","volume":"12","author":"Luo","year":"2011","journal-title":"J Pain."},{"key":"B465","doi-asserted-by":"publisher","first-page":"100045","DOI":"10.1016\/j.ynpai.2020.100045","article-title":"Microbes, microglia, and pain","volume":"7","author":"Dworsky-Fried","year":"2020","journal-title":"Neurobiol Pain."},{"key":"B466","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.expneurol.2015.07.013","article-title":"Nerve injury and neuropathic pain - a question of age","volume":"275","author":"Fitzgerald","year":"2016","journal-title":"Exp Neurol."},{"key":"B467","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbi.2021.07.003","article-title":"Aging and miR-155 in mice influence survival and neuropathic pain after spinal cord injury","volume":"97","author":"Gaudet","year":"2021","journal-title":"Brain Behav Immun."},{"key":"B468","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuron.2020.10.027","article-title":"Mechanical allodynia circuitry in the dorsal horn is defined by the nature of the injury","volume":"109","author":"Peirs","year":"2021","journal-title":"Neuron."},{"key":"B469","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","article-title":"Spared nerve injury: an animal model of persistent peripheral neuropathic pain","volume":"87","author":"Decosterd","year":"2000","journal-title":"Pain."},{"key":"B470","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuroscience.2019.12.040","article-title":"Time course of inflammation in dorsal root ganglia correlates with differential reversibility of mechanical allodynia","volume":"428","author":"Noh","year":"2020","journal-title":"Neuroscience."},{"key":"B471","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain."},{"key":"B472","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1097\/j.pain.0000000000000935","article-title":"Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations","volume":"158","author":"Vollert","year":"2017","journal-title":"Pain."},{"key":"B473","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.pain.2013.05.047","article-title":"Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus","volume":"154","author":"Backonja","year":"2013","journal-title":"Pain."},{"key":"B474","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-pharmtox-010818-021524","article-title":"Neuropathic pain: mechanism-based therapeutics","volume":"60","author":"Bannister","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B475","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.neuron.2021.04.005","article-title":"Human cells and networks of pain: transforming pain target identification and therapeutic development","volume":"109","author":"Renthal","year":"2021","journal-title":"Neuron."},{"key":"B476","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1046\/j.1460-9568.1999.00641.x","article-title":"Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice","volume":"11","author":"Murphy","year":"1999","journal-title":"Eur J Neurosci."},{"key":"B477","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/jcm8060831","article-title":"Achieving pain control in rheumatoid arthritis with baricitinib or adalimumab plus methotrexate: results from the RA-BEAM trial","volume":"8","author":"Taylor","year":"2019","journal-title":"J Clin Med."},{"key":"B478","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S1474-4422(13)70193-5","article-title":"Combination pharmacotherapy for management of chronic pain: from bench to bedside","volume":"12","author":"Gilron","year":"2013","journal-title":"Lancet Neurol."},{"key":"B479","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/brain\/awab048","article-title":"Studying human nociceptors: from fundamentals to clinic","volume":"144","author":"Middleton","year":"2021","journal-title":"Brain."},{"key":"B480","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2017.11.047","article-title":"Human vs. mouse nociceptors - similarities and differences","volume":"387","author":"Rostock","year":"2018","journal-title":"Neuroscience."},{"key":"B481","doi-asserted-by":"publisher","first-page":"14735","DOI":"10.1523\/JNEUROSCI.2919-10.2010","article-title":"Dynamic plasticity of axons within a cutaneous milieu","volume":"30","author":"Cheng","year":"2010","journal-title":"J Neurosci."},{"key":"B482","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1096\/fj.10-162313","article-title":"HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain","volume":"24","author":"Acharjee","year":"2010","journal-title":"FASEB J."},{"key":"B483","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1097\/j.pain.0000000000001973","article-title":"Quantitative differences in neuronal subpopulations between mouse and human dorsal root ganglia demonstrated with RNAscope in situ hybridization","volume":"161","author":"Shiers","year":"2020","journal-title":"Pain."},{"key":"B484","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nbt.2249","article-title":"Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors","volume":"30","author":"Chambers","year":"2012","journal-title":"Nat Biotechnol."},{"key":"B485","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/mt.2014.86","article-title":"Characterizing human stem cell-derived sensory neurons at the single-cell level reveals their ion channel expression and utility in pain research","volume":"22","author":"Young","year":"2014","journal-title":"Mol Ther."},{"key":"B486","doi-asserted-by":"publisher","first-page":"100055","DOI":"10.1016\/j.ynpai.2020.100055","article-title":"Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine","volume":"8","author":"Lampert","year":"2020","journal-title":"Neurobiol Pain."},{"key":"B487","doi-asserted-by":"publisher","first-page":"e0119617","DOI":"10.1371\/journal.pone.0119617","article-title":"Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes","volume":"10","author":"Haile","year":"2015","journal-title":"PLoS One."},{"key":"B488","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/sctm.19-0054","article-title":"Chemotherapy-induced neuropathy and drug discovery platform using human sensory neurons converted directly from adult peripheral blood","volume":"8","author":"Vojnits","year":"2019","journal-title":"Stem Cells Transl Med."},{"key":"B489","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1152\/jn.00933.2017","article-title":"Microneurography: how it started and how it works","volume":"120","author":"Vallbo","year":"2018","journal-title":"J Neurophysiol."},{"key":"B490","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pain.2011.08.015","article-title":"Microneurographic identification of spontaneous activity in C-nociceptors in neuropathic pain states in humans and rats","volume":"153","author":"Serra","year":"2012","journal-title":"Pain."},{"key":"B491","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s12035-019-01861-w","article-title":"CRISPR, prime editing, optogenetics, and DREADDs: new therapeutic approaches provided by emerging technologies in the treatment of spinal cord injury","volume":"57","author":"Paschon","year":"2020","journal-title":"Mol Neurobiol."},{"key":"B492","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.neuron.2019.09.018","article-title":"The genetics of neuropathic pain from model organisms to clinical application","volume":"104","author":"Calvo","year":"2019","journal-title":"Neuron."},{"key":"B493","author":"Alles","year":"2020","journal-title":"Development of Novel Human Induced Pluripotent Stem Cell Derived (hiPSC) Sensory Neuron Lines From Pain Patient Blood Samples"},{"key":"B494","article-title":"Compositions and methods for alleviating pain","author":"Alles","year":"2020"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2021.750583\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:19:42Z","timestamp":1639354782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2021.750583\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":494,"alternative-id":["10.3389\/fpain.2021.750583"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2021.750583","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,13]]},"article-number":"750583"}}